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ABSTRACT OF THE DISSERTATION 
Catalysts for C-N Bond Formation, Polymers for the Delivery of mRNA, and Metal-Ligand 
Mediated Mechanical Gradient Formation 
By 
Nathan John Oldenhuis 
Doctor of Philosophy in Organic Chemistry 
University of California, Irvine 2017 
Professor Zhibin Guan, Co-Chair 
Professor Vy Dong, Co-Chair 
 
 
 In this dissertation, I will discuss the primary authored papers I have published over my 
time at UCI. They cover a broad range of topics, including catalysis, drug delivery, and dynamic 
materials. 
 Chapter 1 is a modified version of a yet to be published book chapter I have written. It will 
discuss green methodology for the construction of amide bonds compared to commonly used 
methods, which generally produce stoichiometric amounts of waste.  
 Chapter 2 is reproduced from a published manuscript that describes a catalytic system using 
a PNP type pincher complex, Ru-Macho, which was discovered to produce amides via 
dehydrogenative coupling of alcohols and amines. This methodology allows for the creation of 
secondary and tertiary amides as well as imines, producing only hydrogen and water as the by-
products. 
 Chapter 3 is reproduced from a published manuscript that describes a catalytic system using 
a PNP type pincher complex, Ru-Macho, which was discovered to produce alpha chiral amines 
via a hydrogen borrowing methodology from secondary alcohols and Ellman’s tert 
xvi 
 
butanesufinylamide. This methodology allows for the creation of high value added alpha chiral 
amines, producing only water as the by-product. 
 Chapter 4 is reproduced from a published manuscript that describes the development of a 
dendronized polymer system for the delivery of mRNA to immortalized and primary cells in vitro. 
In the past decade mRNA delivery has emerged as a promising way to modulate protein expression 
without the need for plasmid DNA transfections. In spite of this need, there are very few synthetic 
vectors currently available for mRNA delivery. We developed a vector, which was able to deliver 
both eGFP and Luc-2 mRNA to 3T3, DC 2.4, and bone marrow derived dendritic cells. 
 Chapter 5 is a yet to be published manuscript which, describes the formation of a 
biomimetic synthetic mechanical gradient material. Large changes in material stiffness at 
interfaces often causes manifestation of damage at the interface during stressing of the material. 
In order to solve this problem, we have developed a synthetic mechanical gradient material based 
of the metal ligand interaction found in the polychaete worm jaw. Using metal imidazole based 
materials previously studied in the lab, we were able to create a material with a continuous metal 
gradient of over 2 orders of magnitude in Young’s modulus. 
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Chapter 1 : Introduction to Acceptorless Dehydrogenate Amide Synthesis 
(This is a modified version of a yet unpublished book chapter I wrote, which felt appropriate to 
include as a lengthy but interesting introduction) 
1.1 Introduction: 
Amide bonds stitch together life's most basic building blocks to create various peptides and 
proteins. Moreover, amides are common intermediates and targets in the creation of new materials 
and medicines. Due to the importance of these bonds there now exist many ways to create amide 
linkages to access endogenous biomolecules, as well as non-endogenous pharmaceuticals, 
synthetic proteins, and more, by a robust set of reagents and methods 1-3. Most commonly used are 
coupling reagents, which operate by activating a carboxylic acid for nucleophilic displacement by 
an amine nucleophile. (Figure 1.1).  These transformations are general and high yielding, but 
typically require an excess of the coupling reagent, as well as a stoichiometric amount of base to 
prevent insoluble carboxylate ammonium salt formation. The excess reagent used in these 
reactions is wasteful 
and can often be toxic. 
A recent survey of 
pharmaceutical manufacturers in 2005 named “amide formation avoiding poor atom economy 
reagents” the number one challenge to address in the coming years 4.   In response to this challenge, 
several new amide-forming reactions have emerged to improve atom economy 5-9.  Methods that 
form amides by catalysis via the release or use of small benign molecules, such as H2O, O2, N2, H2 
etc. are targeted to decrease waste. This chapter will survey amide bond formation through the use 
or loss of H2.  For other promising approaches using catalysis, readers are pointed to recent 
reviews. 1, 8, 10.  
Figure 1.1 Traditional approach to amide bond formation via activated carboxylic group 
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1.2 Dehydrogenative Amide Synthesis (DAS) using alcohols and amines: 
 The first example of amide synthesis from amines and alcohols was explored by Murahashi 
with the formation of lactams from amino alcohols in the presence of RuH2(PPh3)4 
11.  Using 
aldehydes and secondary amines, both γ and δ lactams were synthesized using this system as well 
as tertiary amides. In this seminal work, a stoichiometric amount of a hydrogen acceptor 
(benzylacetone) was required to remove the equivalent of hydrogen from the ruthenium and turn 
over the catalytic cycle.  When the hydrogen acceptor was removed from the reaction, the authors 
noted that direct amination via dehydration 
occurred instead.  Similar catalytic activity for 
lactam formation was observed using Ru3(CO)12, 
RuCl3•H2O, RuCl2(PPh3)3, and RhCl(PPh3)3.  
Many of these metal complexes make later 
appearances in this chapter as precursors for more robust catalytic systems. 
Milstein demonstrated the first dehydrogenative bimolecular amide formation from 
alcohols and amines using a novel tridentate phosphine-nitrogen-nitrogen (PNN)type ruthenium 
(II) pincer complex (Figure 1.2) 12.  The pyridine based pincer complex had previously been shown 
to catalyze ester formation upon activation with base from alcohols via the direct elimination of 
hydrogen gas from the catalyst.  The elimination of dihydrogen directly from the catalyst after 
oxidation was facilitated via a Lewis basic site formed through dearomatization of the pyridine on 
the ligand and the Lewis acidic ruthenium 13-15.  During their optimization studies, the authors 
found that amide formation was favored over ester formation as well as imine and amine formation.  
Considering the oxidative route displayed in Figure 1.3, after the alcohol (3a) is oxidized to the 
carbonyl complex (3b) both the amine and the alcohol could attack 3b producing either a 
Figure 1.2 Pyridine based PNN pincer complex for amide 
bond formation 
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hemiaminal 
(3c) or a 
hemiacetal 
(3g).  From 
there a 
number of competitive pathways are possible.  The hemiacetal can undergo oxidation to generate 
the ester product (3h).  The hemiaminal (3c), can undergo dehydration to afford the imine (3e), 
which upon reduction by the metal-hydride would yield an amine (3f).  Finally, the catalyst can 
oxidize the hemiaminal to yield the amide (3d).  The robust pincer complex affords a variety of 
secondary amides, with only 0.1 mol % of the active complex 2b formed in situ needed for the 
reaction to go to completion (Figure 1.4).  The elimination of stoichiometric reagents, production 
of hydrogen gas as the only by-product, and eventual commercial availability, demonstrated that 
not only was green amide bond formation possible, but would become economically viable.   
While looking for catalysts for amine alkylation with alcohols, Madsen found that 
ruthenium (II) N-Heterocyclic carbene (NHC) phosphine complexes formed amides almost 
exclusively 
(Figure 1.5) 16.  
Considering the 
reaction pathway 
outlined in Figure 
1.3, it easy to see that dehydrogenative amide synthesis (DAS) could compete with alkylation 
pathways. The use of Ru(COD)Cl2 with imidazolium salt 5a, tricyclopentylphosphine, and 
potassium tert butoxide gave the highest yield of amides under reflux in toluene.  A variety of 
Figure 1.3 Potential amidation side products 
Figure 1.4 Selected examples of DAS using complex 2a. 
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primary amines and alcohols 
yielded secondary amides in 
excellent yields.  Stereocenters 
on both the alcohol (5c) and 
amine (5d) were not racemized 
during the transformation.  One 
example of a tertiary amide was 
shown using a secondary amine, 
but to obtain an appreciable amount (40% isolated yield) of amide, the mixture had to be refluxed 
in mesitylene (5e).  This work showed that a ruthenium (II) NHC complex formed in situ 
performed DAS, but required much higher (5 mol % vs 0.1 mol %) catylast loadings and longer 
reaction times (24 h vs 6-12 h) compared to Milstein’s original report.  
Milstein’s report revived an interest in identifying catalytic methods for DAS.  Several 
studies investigating the mechanism 
and new catalysts have since 
appeared.  Another ruthenium (II) 
based system was subsequently 
discovered by the Williams group 17.  
[Ru(p-cymene)Cl2]2 was complexed 
with bis(diphenylphosphino)butane 
(dppb) in the presence of cesium carbonate and refluxed in t-BuOH to form a variety of amides 
from alcohols and amines (Figure 1.6). In accordance with the work to date, the methodology was 
largely limited to less bulky aliphatic amines and alcohols (6a, 6c).  Of note, a tertiary amide was 
Figure 1.5 Madsen's NHC complex formation for DAS. 
Figure 1.6  DAS using dppb as a ligand and 2-Methyl-3-butanone as a 
hydrogen acceptor 
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formed using morpholine, but the yield in this case was lower (6b). 2.5 equivalents of 3-methyl-
2-butanone was used as the hydrogen acceptor, and both this ketone and the corresponding alcohol 
formed upon reduction can easily be removed after reaction due to their low boiling points (~110 
°C).  This system was considered advantageous compared to Milstein’s PNN complex (2b) due to 
the convenient procedure and use of both a commercially available ligand and ruthenium source 
at the time.  However, lower isolated yields, higher catalyst loadings, and longer reaction times 
were also observed 
The Grützmacher group departed from the use of ruthenium and reported DAS from 
alcohols and amines using a rhodium (I) complex 18.  This work focused on reducing the high 
temperatures required for amide 
formation required by both previously 
developed methods. While the 
[Rh(trop2N)(PPh3)] (Figure 1.7, 7b) 
looks much different than both the 
complexes used by Milstein and 
Madsen, it was designed to contain the 
same “cooperative ligand” effects as the 
Milstein catalyst (a Lewis acidic site and 
a Lewis basic site).  According to density 
functional theory (DFT) calculations performed by Grützmacher, the Lewis basic nitrogen atom 
(HOMO) and the Lewis acidic center on the rhodium (LUMO) activate dihydrogen heterolytically.  
While the protocol formed carboxylic acids, esters, and amides in good yields at ambient 
temperatures (~25 °C), the procedure required a hydrogen acceptor (5 equiv of cyclohexanone, or 
Figure 1.7 Rhodium (I) trop2N complex for DAS 
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methyl methacrylate) 
to turn over the 
catalyst.  Using the 
activated complex 
(7b) directly versus 
the precatalyst (7a) 
and base, one can 
produce primary 
amides by DAS from 
ammonia and primary alcohols (7c – 7e).  This result represents the first time ammonia could be 
activated in a DAS reaction.  Benzyl amine was also able to be used to form secondary amides.    
Until 2009, all the complexes used for catalytic amide bond formation from amines and 
alcohols used phosphine ligands to facilitate the reaction.  The Hong group sought a phosphine 
free catalytic system to decrease catalyst deactivation through the decomposition of tertiary 
phosphines via either heat or air 19.  Both [Ru(p-cymene)Cl2]2 (method A) and [Ru(benzene)Cl2]2 
(method B) in tandem with catalytic amounts of sodium hydride, animidazolium salt (8a), and a 
ligand (pyridine or acetonitrile) produce a variety of amides under reflux conditions in toluene 
(Figure 1.8).   The reaction times were slightly longer (36 h), due to a lower catalyst TON as 
compared to Milstein’s 2007 work.  However, compared to the work by Williams ([Ru(p-
cymene)Cl2]2 and dppb), no hydrogen acceptor was  required, thus providing an advantage in terms 
of atom economy. Both catalyst systems were tolerant of aliphatic alcohols and amines to yield 
secondary amides, and showed some effectiveness for tertiary amide formation.  Piperidine , 
morpholine , and N-methylbenzylamine  coupled with various alcohols to give the corresponding 
Figure 1.8 Formation of tertiary amides by Ru NHC complexes 
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tertiary amides 8b, 8c and 8d in good 
yields.  For tertiary amide formation 
with N-methylbenzylamine, reflux in 
mesitylene was required. Using either 
method, no reactivity was observed 
with dibenzylamine, due to the high 
steric encumbrance. 
Several follow up studies were 
published by Hong 20-22 and Madsen 23 
to more thoroughly investigate the 
formation, mechanism, and substrate scope of the ruthenium NHC based-systems for DAS.  The 
Hong group created amidation catalysis using more economical ruthenium (II) or ruthenium (0) 
sources (such as RuH2(PPh3)4, RuCl3, Ru(cod)(cot), Ru Black, Ru on Al2O3, and Ru3(CO)12), a 
NHC precursor, base, and a ligand.  A comparison of the ligands, bases and ruthenium sources is 
shown in Figure 1.9.  Both Hong and Madsen  showed that Grubb’s olefin metathesis catalysts are 
able to mediate the formation of 
amide bonds from amines and 
alcohols as well. This work 
demonstrated that almost any 
ruthenium-based NHC catalyst 
showed some degree of activity 
for amide bond formation.  An additional example was provided by Albrecht using a triazolylidene 
complex instead of an imidazolium-based one (Figure 1.10) 24.   
Figure 1.9 Comparison of ruthenium NHC complexes for  DAS. Cyp = 
Cyclopentyl  
Figure 1.10 Triazolylidene ruthenium (II) complex for DAS 
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Tertiary amide formation using primary 
alcohols and secondary amines has been especially 
challenging.  Both Madsen and Hong tried to 
enhance the formation of tertiary amides by 
reducing the steric bulk of the “wingtip” groups 
(functional groups on the N position of the imidazolium) on the imidazolium salt.  Unfortunately, 
this change did not enable the formation of tertiary amides, and in all cases to this date, isopropyl 
substituents remain the best for amide formation. Both Madsen and Hong did not observe primary 
amides using ammonia (or its surrogates) with the NHC complexes, in contrast to the Rh (I) system 
reported by Grützmacher.  The substrate scope was still largely limited to unhindered aliphatic 
amines and alcohols, but both Madsen and Hong were able to show lactam formation from α,ω 
amino alcohols, and tolerance to tertiary amide from minimally hindered secondary amines. Hong 
further demonstrated that using RuH2(PPh3)4 as a precursor rather than [Ru(p-cymene)Cl2]2 to 
generate a NHC complex greatly increased the ability of the ruthenium (II) complex to form 
amides directly from aldehydes and amines as well as from alcohols and amines.   
To elucidate the structure of the active catalyst, both Madsen and Hong prepared a variety 
of ruthenium NHC complexes (11a) (Figure 1.11).  They postulated that 11b is the active catalytic 
species as free p-cymene was observed while monitoring the reaction via 1H NMR indicating 
disassociation.  Preliminary mechanistic studies showed that the formation of a ruthenium hydride 
species through the action of a base was likely a key step in forming the active catalytic species.  
Amide bond formation was not observed when no base was added.   An interesting observation by 
Madsen was that imine formation seemed to hinder amide formation.  Amines were combined with 
mixtures of aldehyde (which condenses with the amine to form the imine immediately) and alcohol 
Figure 1.11 In situ generated ruthenium NHC catalyst 
species 
9 
 
to measure if the amide product was still observed.  Formation of the amide product decreased as 
the amount of aldehyde present in the system increased.  This indicated that the aldehyde formed 
from oxidation of the alcohol must stay partially or fully coordinated to the catalyst during the 
reaction, and remains on the metal center until a suitable nucleophile approaches. 
Hong followed up with a paper 
addressing the formation of tertiary 
amides from secondary amines and 
alcohols using a NHC precatalyst 
derived from [Ru(benzene)Cl2]2 (Figure 
1.12) 25.  Much like their previous 
investigations, preparing the ruthenium 
(II) NHC “precatalyst” beforehand, 
rather than in situ, led to more efficient tertiary amide bond formation  (12b – 12d).  They 
postulated that the dissociation of the arene is necessary to form the active catalytic species.  An 
increased reaction rate was observed using the benzene complex over the cymene complex. This 
effect was attributed to the less sterically hindered and more electron deficient benzene being able 
to disassociate faster to form the active complex.  However, ester formation was observed using 
12a and not in the case of the p-cymene complex.  Increasing the amount of base (35 mol %) was 
necessary to increase tertiary amide formation, with a simultaneous decrease in ester formation.  
The authors did not rule out the possibility that ester formation might occur followed by trans-
amidation with the secondary amine to yield the desired product.  In summary, this work was the 
first to demonstrate tertiary amide synthesis in reasonable yields, as well as the ability to step away 
from unencumbered secondary amines to use bulkier secondary amines such as dibenzyl amine.  
Figure 1.12 Ruthenium NHC complex for tertiary amide formation 
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In similar work reported by Milstein in 
2013, a new dipyridine PNN (13a) type 
catalyst was shown to have activity towards 
tertiary amide formation (13c - 13d) but 
could not react with highly encumbered 
dibenzylamine (13b) (Figure 1.13) 26. 
To deduce what components of 
catalyst design were important for DAS, 
the Crabtree group studied a variety of diphosphine diamine catalysts (Figure 1.14) based on an 
amidation catalyst developed by the Williams group (14a) in a model lactamization reaction 27.  In 
the cases where the diphosphine was not present, much lower activity in lactam formation was 
observed (14e).  In the diamine, if there were no N-H bonds present, TOFs were reduced (14b, 
14d).  They reasoned through computational studies that the N-H bond helps stabilize both the 
aldehyde and 
hemiaminal 
intermediates 
through 
preventing them 
from disengaging 
from the catalyst 
and forming 
imines, which can 
interrupt and 
Figure 1.14 Ruthenium NHC complex for tertiary amide formation 
Figure 1.13  Diphosphine diamine complexes prepared for study of DAS synthesis 
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shut down the catalytic cycle (14a, 14c, 14f).  While the structures of these catalysts were similar 
to previously mentioned systems, Crabtree’s study provided insights to influence future catalyst 
design.  
In a follow-up study, Milstein focused on making cyclic dipeptides, as well as pyrazines 
using their PNN- (15a) and PNP-based (15b) pincer complexes (Figure 1.15) 28.  β-Amino alcohols 
in combination with the PNN complex were shown to favor forming the cyclic dipeptide (15c, 
15d).  When alaninol (R = Me) was used, the polyamide was obtained instead.  Pyrazine formation 
could be promoted with the PNP complex (15b) which is known to promote imine formation over 
amide formation.  A cyclic diimine intermediate is obtained that spontaneously oxidizes to the 
substituted pyrazine (15e, 15f).  Accessing symmetrically substituted pyrazines is an important 
advance because these structures are present in a number of pharmacologically active complexes. 
 In a related study, the Glorius group used methanol as the alcohol in DAS to form primary 
formamides.  To drive the reaction to completion, a new NHC ruthenium (II) complex was 
developed derived 
from [Ru(cod)(2-
methylallyl)2] and 
the imidazolium salt 
16a (Figure 1.16).  
Previous catalysts 
were unsuccessful 
for this 
transformation 
because the 
Figure 1.15 Synthesis of cyclic dipeptides and pyrazines using amino alcohols and PNN or PNP Ru 
complexes 
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formation of formamides 
is thermodynamically 
disfavored.  There was a 
concern that urea 
derivatives could be 
formed under the 
reaction conditions 
through oxidative amidation of the formamide product.  However, formamide formation through 
DAS proceeded in good yields (16b - 16e).  Styrene was required as an additive in the production 
of the formamides in high yields because the catalyst could not turnover without the assistance of 
a hydrogen acceptor.  
 With a focus on the oxygen-source, Milstein developed an amidation methodology using 
water to oxidize cyclic amines to lactams 
29.  With the more active acridine PNP 
complex 17a, secondary cyclic amines are 
activated via the removal of hydrogen to 
form an imine, and then through reversible 
hydration to form the hemiaminal. Finally, 
the catalyst oxidizes the hemiaminal to 
form the lactam in good yields (17b – 
17e).  They also report the synthesis of 
lactams from diols and ammonium hydroxide as an ammonia equivalent.  The oxidation of amines 
Figure 1.16 Formylation of amines with methanol via DAS 
Figure 1.17 DAS of formamides using water as oxidant 
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using water is a major advancement in green oxidation methods for DAS, but at this point requires 
rather harsh conditions in the form of high reaction temperatures and only gives modest yields. 
1.3 Mechanistic Considerations of Homogeneous DAS: 
 To date, several mechanistic studies have been published with a focus on DAS 
(dehydrogenative amide synthesis).  To prevent redundancy, we direct the readers to the studies 
themselves for an in depth discussion of the mechanistic 
considerations for each of the catalytic systems studied 30-37.  
In this brief section, we will provide what we consider the 
most important mechanistic facets of DAS from alcohols and 
amines across the catalysts previously surveyed.  There are 
two mechanistic pathways that will be discussed, as well as 
the energetics of amide bond formation versus the competing 
pathways listed in Figure 1.3.   
 In a simplified view of the reaction, DAS can be summarized in the 4 key steps illustrated 
in Figure 1.18.  Initially, a metal complex oxidizes an alcohol to an aldehyde via removal of 
hydrogen.  The catalyst then eliminates the equivalent of hydrogen directly or with the help of a 
hydrogen acceptor while simultaneously the aldehyde 
undergoes nucleophilic attack by the amine to form the 
hemiaminal intermediate.  In the final step, the hemiaminal 
is further oxidized by the catalyst to form the amide product 
with   the catalyst regenerated via removal of hydrogen.  
Figure 1.18 Key mechanistic steps of DAS 
from alcohols and amines 
Figure 1.19 Schematic  of ß Hydride 
elimination of alcohols and hemiaminals 
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Upon the discovery of DAS, the operative mechanism was thought to involve β-hydride 
eliminations from both the alcohol and hemiaminal as the key steps to form a supposed aldehyde 
intermediate and product respectively (Figure 1.19).  This β-hydride elimination could potentially 
be operative in all the above-mentioned systems, but requires the amine group of the PNN ligand 
to be hemilabile in order to allow an open coordination site on the ruthenium center. (Figure 1.20).    
This disassociation is thought to be too high in energy to be feasible.  However, pincer ligands 
presented by Milstein, Grutzmacher, Dong, and Guan could proceed through an additional 
mechanism involving a bifunctional double hydrogen transfer (BDHT) (Figure 1.21). In the BDHT 
mechanism, no hemilabile ligand is required, which could explain why the pincer complexes (used 
by the Grutzmacher group) facilitate DAS despite lacking this feature. 
In light of the possible reaction pathways, common observations found during the initial 
studies help confirm certain mechanistic aspects of DAS from alcohols and amines. For example, 
the free aldehyde and hemiaminal tend not to be observed during the course of the reaction, despite 
early theories that the hemiaminal re-binds to the catalyst after being initially formed in solution.  
This suggests that the aldehydic intermediate must remain bound to the catalyst during the overall 
oxidation process from alcohol to amide.  This proposal is further supported by the observation 
that the catalysts, which are observed to release the aldehyde after the initial oxidation, favor direct 
amination and imine formation as opposed to amidation.  If hemiaminal formation occurs through 
a non-catalytic pathway, dehydration to either the imine 34, 38 or amine product out-competes 
Figure 1.20 Example of hemilable ligand site required for ß-hydride elimination of alcohol  using PNN 
catalyst 
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sequential oxidation to 
form the amide.  For a 
catalyst to be active in 
DAS, the oxidation of the 
hemiaminal species by the catalyst must out-compete dehydration to imine intermediates. 
  These mechanistic studies demonstrate that DAS mainly out-competes dehydrogenative 
ester synthesis, and computational studies (LANL2DZ) 34 show that hemiaminal formation is 
favored over hemiacetal formation (the intermediate in dehydrogenative ester synthesis) when 
using primary amines.  Unsurprisingly, when sterically hindered secondary amines are considered, 
the rate of hemiacetal formation is faster than hemiaminal formation because the lower 
nucleophilicity of secondary amines makes the hemiaminal formation higher in energy than 
hemiacetal formation. This trend was observed in several cases, and when highly sterically 
encumbered amines are used in DAS, ester formation is exclusively observed.  
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Chapter 2 : Catalytic acceptorless dehydrogenations: Ru-Macho catalyzed construction of 
amides and imines 
Abstract: 
A commercially available ruthenium (II) PNP type pincer catalyst (Ru-Macho) promotes 
formation of amides and imines from alcohols and amines via an acceptorless dehydrogenation 
pathway. The formation of secondary amides, tertiary amides, and secondary ketimines occurs in 
yields ranging from 35%–95%. 
2.1: Introduction 
Amide bonds are prevalent in natural products, proteins, and synthetic materials. The 
formation of amide linkages is one of the most executed transformations in organic chemistry. 
Traditional methods for amide bond formation often involve harsh conditions and/or generate a 
stoichiometric amount of waste.1-3 With growing environmental concerns, there is a need for more 
efficient, atom economical, and environmentally friendly methods for amide synthesis. As an 
indication, the formation of amide bonds via green methods was named the number one challenge 
for organic chemists by the ACS Green Chemistry Institute in 2007.4 To address this challenge, a 
variety of new methodologies have emerged.3 Among them, acceptorless catalytic 
dehydrogenation has received particular attention for its ability to form amide bonds directly from 
alcohols and amines5-10 (Scheme 2.1). Catalytic acceptorless dehydrogenative amide synthesis 
circumvents the need for a stoichiometric oxidizing agent or sacrificial hydrogen acceptor by 
evolving hydrogen gas directly from the reaction.11 A number of laboratories5-8, 12-17 have 
demonstrated promising catalysts for amide bond formation via dehydrogenation using Ruthenium 
catalysis. Our group previously employed the Milstein catalyst (1) for the synthesis of 
polyamides.18  Others have also applied acceptorless dehydrogenation to the direct synthesis of 
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esters,19-21 lactones,6, 19 imines, 16, 22-26 
and pyrroles6, 27, 28. While searching for 
improved polyamidation catalysts, we 
discovered in this work that a 
commercially available, relatively 
inexpensive catalyst (complex 3, Scheme 
2.1) catalyzed the synthesis of a variety 
of secondary and tertiary amides, as well 
as secondary ketimines from alcohols 
and amines. 
Given the potential of 
acceptorless dehydrogenation for amide bond formation, 29 we sought to identify inexpensive and 
robust catalysts that could produce amide bonds. Previous studies demonstrated that the catalytic 
cycle did not rely on redox chemistry at the metal, but rather on metal/ligand cooperation.14, 30 In 
both the Milstein catalyst (1) and the Grützmacher catalyst (2), the catalytic process was proposed 
to proceed through cooperative interactions of substrates with the basic site of the ligand and with 
the electrophilic metal centerutilizing catalysts based off the works of Shvo, Murahashi and 
others17, 31-33 (Scheme 2.1). A hydrogen acceptor is not necessary because the ligands play an active 
role in the hydrogen abstraction and liberation process. The bulky ligands in these catalysts, 
however, may hinder the ability of the substrate to interact with both sites of the complex, which 
may explain why tertiary amides are difficult to synthesize via reported acceptorless 
dehydrogenation systems5, 6, 8, 9, 15. Of note, Ru-NHC complexes have also emerged as promising 
catalysts.8-10 
Figure 2.1 Acceptorless dehydrogenation of an amine and alcohol to 
form an amide. All catalysts shown contain a cooperative basic site on 
the ligand. 
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The commercially available PNP type ruthenium (II) catalyst, 
(RuHCl(CO)(HN(CH2CH2PPh2)2)) pioneered by the Saito group (Ru-Macho, Scheme 2.1, 
complex 3) has recently been reported to efficiently hydrogenate esters to form the corresponding 
alcohols.34, 35 In this context, hydrogenation and dehydrogenation are reversible reactions, we 
hypothesized that this industrially relevant catalyst could be used for dehydrogenative amide 
formation. Complex 3 has a number of desirable attributes for our purpose. Firstly, similar to 
catalysts 1 and 2, complex 3 contains a basic site on the ligand to provide the desired cooperative 
interactions between the substrate and the metal/ligand framework (Scheme 2.1, complex 3).  
Secondly, the ligand in complex 3 is less bulky than those in 1 and 2, which may broaden the 
substrate scope relative to pincer type ligands.  Importantly, the precursor of complex 3 is 
commercially available and relatively inexpensive. Lastly, it has previously demonstrated robust 
catalytic activity in ethyl acetate formation from ethanol20 as well as methanol water reformation,36 
and is used in large scale industrial applications.34   
2.2: Results and Discussion 
First, we investigated the feasibility of direct amidation by complex 3, by using 2-
methoxyethanol and benzyl amine as model substrates (see SI, Table 2.3). A number of 
experimental parameters, including the base, solvent, and H2 removal were varied. To form the 
catalytically active complex 3, the pre-catalyst 4 must be activated with a base (Scheme 2.2). Initial 
attempts using NaOEt or NaOtBu as the base resulted in no amide formation. Upon changing to 
sodium hydroxide as the base, however, amide bond 
formation was observed. Because the base appeared to 
have an effect on direct amidation, the base and counter-
Figure 2.2 Activation of Ru-Macho precatalyst 4 
with base to form the active catalyst 3 
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ion was further investigated. 
Among all bases evaluated 
(LiOH, NaOH, KOH, 
Na2CO3, K2CO3, NaOEt, and 
NaOtBu), potassium 
hydroxide promoted the 
highest yield of the desired 
amide (see 2.4, Table 2.3). 
Using KOH as the base, we 
investigated the solvent effect 
for this transformation. 
Among the list of both polar 
and nonpolar solvents 
examined, toluene and 
dioxane gave the highest yield 
(~66%). Because catalyst 3 
can catalyze hydrogenolysis 
of esters and amides with the 
H2 generated during 
dehydrogenation, removal of  
H2 was necessary prevent the 
reverse transformation.34 
Table 2.1. Amide bond formation by acceptorless dehydrogenations of amines 
and alcohols with Ru-Macho catalyst 
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Indeed, introducing continuous nitrogen flow through the reaction flask afforded almost 
quantitative amide formation.  
With this protocol in hand (1 mol% complex 4, 15 mol% KOH, reflux, toluene, nitrogen 
flow), several amines and alcohols were examined as coupling partners for amide bond formation. 
A variety of amides (Table 2.1, entries 1–15) were obtained in good to excellent yields, 
demonstrating the efficiency and versatility of complex 3 in amide bond formation. Simple linear 
aliphatic alcohols coupled efficiently (entries 1–2).  Similarly, aliphatic alcohols with α-branching 
also produced amides in high yields (entry 3).  Ether and tertiary amine groups were well-tolerated 
in the amidation process (entries 5 & 7). An aniline substrate, which is less nucleophilic than 
aliphatic amines, afforded amide in 79% yield (entry 6). To test whether optically active amines 
were racemized or not during the amidation, an optically pure amine was subjected to the catalytic 
protocol.  The optically pure amide was obtained in high yield (entry 8), suggesting no significant 
racemization occurs during the dehydrogenative coupling (see experimental).  After successful 
amidation with a variety of mono-amines and mono-alcohols, diamines (entry 9) and diols (entry 
10) were coupled to form diamides in high yields, suggesting the applicability of making 
polyamides using complex 3.18 
The ability of the secondary amines to undergo coupling  stands out (Table 2.1, entries 11–
15) because previously reported acceptorless dehydrogenation catalysts have limited conversion 
for forming tertiary amides directly from secondary amines and alcohols5, 6, 8, 15 or require high 
catalyst loadings9.  Morpholine and piperidine were both coupled in 89% and 86% yield, 
respectively (entries 11, 12). A linear secondary amine with moderate steric bulk was coupled in 
very good yield (entry 13). Systematically increasing steric bulk of the secondary amine resulted 
in decreasing yield (entries 13–15). Nevertheless, a more sterically encumbered secondary amine, 
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dibenzylamine, underwent 
coupling with moderate 
yield (entry 15). This 
result suggests that further 
ligand tuning may open 
the door to the direct 
synthesis of more 
sterically hindered tertiary 
amides, which are very 
difficult to access.3  
Acceptorless 
dehydrogenative catalysts 
have also been shown to 
afford secondary 
aldimines from primary alcohols and amines.16, 22-26 However, synthesis of secondary ketimines 
via the acceptorless hydrogenation pathway remains problematic.22, 24 Considering that complex 3 
could couple secondary amines efficiently, we reasoned that ketimine formation would be feasible. 
Using complex 3, cyclohexanol and benzylamine were shown to undergo coupling to generate 
secondary ketimines (Table 2.2, entry 1) in nearly quantitative yields on the basis of  GC-MS and 
1HNMR analysis.37 Borohydride reduction of the resulting imines leads to isolated yields for the 
reduced products between 40-
91%. Our results represent the 
highest yielding examples of 
Table 2.2 Imine bond formation via acceptorless dehydrogenations of amines and alcohols 
by Ru-Macho catalyst 
Figure 2.3 Hemiaminal 5a can either form an amide (5b) or imine (5c) depending 
on the identity of R'. 
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secondary alcohols and amines undergoing dehydrogenative coupling to generate secondary 
ketimines.  More sterically hindered and acyclic alcohols transformed to the corresponding 
ketimines in moderate yields (entries 2–5).  
The ability of complex 3 to form both amides and imines results from the common 
hemiaminal intermediate generated after the dehydrogenative coupling of the alcohol and the 
amine (Scheme 2.3).  Typically, the hemiaminal (5a) undergoes another dehydrogenation via 
complex 3 to create the amide product (5b).  However, if the R’ substituent on the hemiaminal is 
a moiety other than a hydrogen atom, complex 3 is unable to undergo elimination of an equivalence 
of dihydrogen. Thus, imine formation is favored through dehydration in the case of secondary 
alcohols due to no other competing pathway. 
2.3: Conclusions 
The catalyst 3 (Ru-Macho) investigated here has shown utility for both amide and imine 
bond formation through the acceptorless dehydrogenation pathway. As an advance, we 
demonstrate good reactivity with secondary amines for the synthesis of tertiary amides and an 
improved synthesis of ketimines from secondary alcohols. The combination of commercial 
availability, relatively low cost, and general substrate scope makes Ru-Macho an attractive catalyst 
for amide and imine bond formation. Future studies will focus on stereoselective variants and using 
these insights towards the construction of polyamides. 
2.4: Supporting Information 
General Reagent Information: All reactions were set up under a nitrogen atmosphere in 
a Vacuum Atmospheres Company Glove box. Reactions that were carried out outside of the glove 
box were performed under a nitrogen atmosphere using standard Schlenk techniques. Toluene was 
purchased from Fischer Chemical and purged with argon for 2 hours, then dried by passing it 
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through two columns of neutral alumina under argon pressure. Dioxane, DMF, DMSO, 
chlorobenzene, xylene, and DMF were purchased from Aldrich Chemical Co or Fischer Chemical, 
and purged with nitrogen for 30 mins before use. Amines and alcohols were purchased at reagent 
grade or higher purity from Aldrich Chemical Co, or Fischer Chemical and purged with nitrogen 
for 30 minutes before use. [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) was purchased from Strem 
Chemicals Inc. and used as received. KOH was purchased from Fisher Chemical, ground with a 
mortar and pestle in the glovebox to a fine powder, and stored in the glove box. Column 
chromatography was performed using silica gel (Dynamic Adsorbents Inc. Silica, C-18 32-63µ, 
60A) and eluted using applied air pressure with the indicated solvent system.  
General Analytical Information: All compounds were characterized by 1HNMR, 
13CNMR, ESI-MS, and IR. NMR spectra were obtained using Bruker 500 MHz instruments. All 
1HNMR and 13CNMR are reported in ppm relative to TMS (0.00 ppm) unless otherwise noted. IR 
spectra were obtained using a Thermo Scientific Nicolet iS5 iD5 ATR IR spectrometer. GC-MS 
(CI) was performed using a GCT Premier Micromass MS Technologies mass spectrometer, 
coupled with a Waters 7890A gas chromatograph. ESI MS was performed using a LCT Premier 
Micromass MS Technologies mass spectrometer. 
 
 
 
Table 2.3 Reaction Optimization 
 
Entry Solvent Base GC Yield (%) 
1 Toluene LiOH 2 
2 Toluene NaOH 32 
3 Toluene KOH 44 
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4 Toluene Na2CO3 0 
5 Toluene K2CO3 5 
6 Toluene KOtBu 21 
7 Toluene NaOEt 0 
8 Toluene N/A 0 
9 Diglyme KOH 4 
10 Anisole KOH 6 
11 Toluene KOH 66 
12 Xylene KOH 59 
13 DMSO KOH 3 
14 DMF KOH 2 
15 Dioxane KOH 66 
16 Chlorobenzene KOH 11 
17 NMP KOH 9 
18 Neat KOH 24 
19 Toluene KOH 98 
 
General Procedure for Examples in Table 2.3: A 1 dram vial was equipped with a stir bar and 
brought into the glove box through the antechamber, after evacuating and backfilling the 
antechamber with nitrogen 3 times. Once inside the glove box, the vial was charged with 
[RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), a base (0.15 mmol, 15 mol 
%), a solvent (1 M), benzylamine (107 mg, 1 mmol, 1.0 equiv.) and 1-octanol (130 mg, 1 mmol, 
1.0 equiv.) in that order. The vessel was then fitted with an air-tight septum, removed from the 
glove box, and heated to 90 °C in an aluminum heating block under N2 pressure via a needle 
through the septum. During this time, nitrogen is passed through the Schlenk line allowing the 
hydrogen evolved from the reaction to escape the vessel. After 12 h, the vial was removed from 
the aluminum block and the yield of the reaction was determined by GC analysis, using a known 
amount of dodecane as an internal standard. In entry 19, nitrogen was flowed through the reaction. 
General Procedure for Examples in Table 2.1 in Main Text: An oven dried 10 mL round 
bottom flask equipped with a stir bar was brought into the glove box with a reflux condenser. The 
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flask was charged with [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), 
KOH (8.2 mg, 0.15 mmol, 15 mol %), and toluene (1.0 mL), an amine (1 mmol, 1.0 equiv.) and 
an alcohol (1 mmol, 1.0 equiv.) in that order. After all reagents have been added to the flask, the 
reflux condenser was attached and secured with a keck clamp. The top of the condenser was sealed 
with a septum and the whole apparatus was then removed from the glove box. Once outside the 
glove box, the apparatus was equipped to nitrogen flow by inserting an inlet needle supplying a 
positive pressure of nitrogen into the septum, and an outlet needle connected to an oil bubbler. The 
reaction mixture was heated at reflux in a silicone oil bath overnight (12 h), then allowed to cool 
to RT, and the conversion determined by GC-MS (CI). The resulting residue was subjected to flash 
chromatography with the indicated solvent system to obtain the purified amide in the reported 
isolated yield. 
General Procedure for Examples in Table 2.2 in Main Text: An oven dried 10 mL round 
bottom flask equipped with a stir bar was brought into the glove box with a reflux condenser. The 
flask was charged with [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), 
KOH (8.2 mg, 0.15 mmol, 15 mol %), and toluene (1.0 mL), an amine (1 mmol, 1.0 equiv.) and 
an alcohol (1 mmol, 1.0 equiv.) in that order. After all reagents had been added to the flask, the 
reflux condenser was attached and secured with a keck clamp. The top of the condenser was sealed 
with a septum and the whole apparatus was removed from the glove box. Once outside the glove 
box, the apparatus was equipped to nitrogen flow by inserting an inlet needle supplying a positive 
pressure of nitrogen into the septum, and an outlet needle connected to an oil bubbler. When the 
transformation was deemed complete on the basis of analysis by GC-MS (CI), the reaction mixture 
was allowed to cool to rt. 5 mL MeOH was added, and the resulting mixture was stirred until the 
solution was homogeneous. NaBH4 (95 mg, 2.5 mmol, 2.5 equiv.) was added through the top of 
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the flask, exposing the reaction to the atmosphere. The solution was stirred for 1 h at room 
temperature. After 1 h, 3.5 mL 1M HCl was added drop-wise. The solution was then diluted with 
50 mL of EtOAc, washed with 1M KOH (3 x 50 mL), and finally brine (3 x 50 mL). The organic 
layer was then dried with MgSO4 and the excess solvent was removed in vacuo. The resulting 
residue was subjected to flash chromatography. 
Preparation and Analysis of Compounds: 
N-benzyloctanamide. (Table 2.1, Entry 1) The general procedure for Table 2.1 was followed 
using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (5.5 mg, 0.0915 mmol, 0.01 eq.), KOH (7.7 mg, 
0.137 mmol, 15 mol %), benzylamine (100 μL, 0.915 mmol, 1.0 eq.), 1-octanol (144 μL, 0.915 
mmol, 1.0 eq.) and toluene (1.5 mL). The product was purified via flash chromatography with 
EtOAc in Hexanes (1:4) to give a clear oil (194 mg, 91% isolated yield). 1HNMR (500 MHz, 
CDCl3) δ 7.40 (m, 2H) 7.34 (m, 3H) 5.72 (br, s, 1H) 4.51 (d, J = 5.5 Hz, 2H) 2.27 (t, J = 7.5 Hz, 
2H) 1.72 (m, 2H) 1.36 (m, 8H) 0.94 (t, J = 7.5 hz, 3H) ppm. 13CNMR (125 MHz, CDCl3) δ 173.0, 
138.5, 128.7, 127.8, 127.5, 43.55, 36.8, 31.7, 29.3, 29.1, 25.8, 22.6, 14.1 ppm. The physical data 
were identical in all respects to those previously reported. 38 
N-benzylbutyramide. (Table 2.1, Entry 2) The general procedure for Table 2.1 was followed 
using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), KOH (8.2 mg, 0.15 
mmol, 15 mol %), benzylamine (107 mg, 1.0 mmol, 2.0 eq.), 1-butanol (74 mg, 1.0 mmol, 1.0 eq.), 
and toluene (1 mL). The product was purified via flash chromatography with EtOAc and hexanes 
(1:4) to give a white solid (168 mg, 95% isolated yield). 1HNMR (500 MHz, CDCl3) δ 7.35 – 7.26 
(m, 5H), 6.60 (br, s, 1H), 4.45 (d, J = 7.5 Hz, 2H), 2.19 (t, J = 7 Hz, 2H), 1.69 (m, 2H), 0.96 (t, J 
= 7 Hz, 3H) ppm. 13CNMR (125 MHz, CDCl3) δ 173.1, 138.6, 128.7, 127.8, 127.4, 43.5, 38.6, 
19.3, 13.9 ppm. The physical data were identical in all respects to those previously reported. 39  
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N-benzyl-2-methylbutanamide. (Table 2.1, Entry 3) The general procedure for Table 2.1 was 
followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), KOH (8.2 
mg, 0.15 mmol, 15 mol %), benzylamine (107 mg, 1.0 mmol, 1.0 equiv.), 2-methyl-1-butanol (87 
mg, 1.0 mmol, 1.0 equiv.), and toluene (1 mL). The product was purified via flash chromatography 
with EtOAc and hexanes (1:4) to give a white solid (171 mg, 90%). 1HNMR (500 MHz, CDCl3) δ 
7.34 - 7.26 (m, 5H), 5.83 (br, s, 1H), 4.44 (m, 2H), 2.14 (m, 1H), 1.70 (m, 1H), 1.43 (m, 1H), 1.16 
(d, J = 5 Hz, 3H), 0.91 (t, J = 5 Hz 3H) ppm. 13CNMR (125 MHz, CDCl3) δ 176.4, 138.6,  128.7, 
127.8, 127.4, 43.5, 43.3, 27.4, 17.6, 12.0 ppm. The physical data were identical in all respects to 
those previously reported. 4 
N-benzylbenzamide. (Table 2.1, Entry 4) The general procedure for Table 2.1 was followed 
using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), KOH (8.2 mg, 0.15 
mmol, 15 mol %), benzylalcohol (108 mg, 1.0 mmol, 1.0 equiv.), benzylamine (107 mg, 1.0 mmol, 
1.0 equiv.), and toluene (1 mL). The product was purified via flash chromatography with EtOAc 
and hexanes to give a white solid (194 mg, 92% isolated yield). (500 MHz, CDCl3) δ 7.80 (d, J = 
7, 2H), 7.48 (m, 1H) 7.42 (t, J = 7 Hz, 2H), 7.36–7.28 (m, 5H), 6.48 (br, s, 1H), 4.65 (d, J = 5.5 
Hz, 2H) ppm. 13CNMR (125 MHz, CDCl3) δ 167.4, 138.2, 134.4, 131.6, 128.9, 128.7, 128.0, 
127.7, 127.0, 44.2 ppm. The physical data were identical in all respects to those previously 
reported.40  
N-benzyl-2-methoxyacetamide. (Table 2.1, Entry 5) The general procedure for Table 2.1 was 
followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.2 mg, 0.01 mmol, 1 mol %), KOH (8.3 
mg, 0.15 mmol, 15 mol %), benzylamine (107 mg, 1.0 mmol, 1.0 equiv.), 2-methoxyethanol (76 
mg, 1.0 mmol, 1.0 equiv.), and toluene (1.0 mL). The product was purified via flash 
chromatography with EtOAc and Hexanes (1:4) to give a clear oil (170 mg, 95% isolated yield). 
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1HNMR (500 MHz, CDCl3) δ 7.36–7.26 (m, 5H), 6.82 (br, s, 1H), 4.49 (d, J = 10 Hz, 2H), 3.95 
(s, 2H), 3.40 (s, 3H) ppm. 13CNMR (125 MHz, CDCl3) δ 169.5, 138.1, 128.8, 127.9, 127.6, 72.0, 
59.2, 42.9 ppm. The physical data were identical in all respects to those previously reported. 43 
2-methoxy-N-(4-methoxyphenyl)acetamide. (Table 2.1, Entry 6) The general procedure for 
Table 2.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol 
%), KOH (8.2 mg, 0.15 mmol, 15 mol %), p-anisidine (107 mg, 1.0 mmol, 2.0 equiv.), 2-
methoxyethanol (76 mg, 1.0 mmol, 1.0 equiv.), and toluene (1 mL). The product was purified via 
flash chromatography with EtOAc and hexanes (1:3) to give a clear oil (154 mg, 79%). HRMS 
(ESI/CH2Cl2) m/z calcd for C10H13NO3Na (M + Na)
+: 218.0793, Found: 218.0797. 1HNMR (500 
MHz, CDCl3) δ 8.14 (br, s, 1H), 7.47 (d, J = 9.0 Hz, 2H) 6.87 (d, J = 9.0 Hz, 2H) 4.01 (s, 2H) 3.80 
(s, 3H), 3.50 (s, 3H) ppm. 13CNMR (125 MHz, CDCl3) δ 167.3, 156.6, 130.3, 121.6, 114.2, 72.2, 
59.3, 55.5 ppm. IR (film) 3003.1, 2917.6, 2849.0, 1679.8, 1511.8, 1246.1, 1110.9, 1033.5 cm-1. 
N-benzyl-2-(diethylamino)acetamide. (Table 2.1, Entry 7) The general procedure for Table 2.1 
was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), KOH 
(8.2 mg, 0.15 mmol, 15 mol %), benzylamine (107 mg, 1.0 mmol, 1.0 equiv.), N,N’-
diethylethanolamine (117 mg, 1.0 mmol, 1.0 equiv.), and toluene (1 mL). The product was purified 
via flash chromatography with EtOAc and hexanes (1:1) to give a clear oil (193 mg, 88% isolated 
yield). 1HNMR (500 MHz, CDCl3) δ 7.71 (br, s, 1H), 7.35-7.62 (m, 5H) 4.75 (d, J = 6 Hz, 2H) 
3.08 (s, 2H) 2.54 (q, J = 7.0 Hz, 4H) 0.99 (t, 6H, 7.0 Hz) ppm. 13CNMR (125 MHz, CDCl3) δ 
172.1, 138.6, 128.7, 127.6, 127.4, 57.5, 48.8, 43.0, 12.4 ppm. The physical data were identical in 
all respects to those previously reported. 41 
(R)-2-methoxy-N-(1-phenylethyl)acetamide. (Table 2.1, Entry 8) The general procedure for 
Table 2.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol 
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%), KOH (8.2 mg, 0.15 mmol, 15 mol %), (R)-(+)-methylbenzylamine (121 mg, 1.0 mmol, 1.0 
equiv.), 2-methoxyethanol (76 mg, 1.0 mmol, 1.0 equiv.), and toluene (1 mL). The product was 
purified via flash chromatography with EtOAc and hexanes (1:4) to give a colorless solid (169 mg, 
88%). [a]D
25 +109.9 (c = 2.0, MeOH) 1HNMR (500 MHz, CDCl3) δ 7.52-7.24 (m, 5H), 6.85 (br, 
s, 1H), 5.18 (m, 1H), 3.91-3.83 (m, 2H), 3.41 (s, 3H), 1.52 (d, J = 7.5, 3H) ppm. 13CNMR (125 
MHz, CDCl3) δ 168.4, 143.0, 128.8, 127.4, 126.1, 72.1, 59.1, 48.0, 21.9 ppm. The physical data 
were identical in all respects to those previously reported. 42 
N,N'-(1,4-phenylenebis(methylene))bis(2-methoxyacetamide). (Table 2.1, Entry 9) The 
general procedure for Table 2.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 
mg, 0.01 mmol, 1 mol %), KOH (8.2 mg, 0.15 mmol, 15 mol %), p-xylenediamine (136 mg, 1.0 
mmol, 1.0 equiv.), 2-methoxyethanol (155 mg, 2.0 mmol, 2.0 equiv.), and toluene (1 mL). The 
product was purified via flash chromatography with EtOAc and hexanes (9:1) to give a white solid 
(265 mg, 95% isolated yield). HRMS (ESI/CH2Cl2) m / z calcd for C14H20N2O4Na (M + Na)
+: 
303.1321, Found: 303.1331. 1HNMR (500 MHz, DMSO-d6) δ 8.32 (t, J = 6.0 Hz, 1H) 7.19 (s, 4H) 
4.25 (d, J = 6.0 Hz, 4H) 3.84 (s, 4H) 3.31 (s, J = 7.0 Hz, 6H) ppm. 13CNMR (125 MHz, DMSO-
d6) δ 169.4, 138.5, 127.7, 72.0, 59.1, 41.9. IR (solid) 3029.1, 2939.7, 2831.2, 1650.8, 1532.0, 
1197.4, 1109.3, 733.1 cm-1 
2,2'-((oxybis(ethane-2,1-diyl))bis(oxy))bis(N-benzylacetamide). (Table 2.1, Entry 10) The 
general procedure for Table 2.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (12.0 
mg, 0.02 mmol, 1 mol %), KOH (16.4 mg, 0.3 mmol, 15 mol %), benzylamine (219 mg, 2.05 
mmol, 2.05 equiv.), tetraethylene glycol (194 mg, 1.0 mmol, 1.0 equiv.), and toluene (1 mL). The 
product was purified via flash chromatography with EtOAc and hexanes (1:4) to give a clear oil 
(360 mg, 90% isolated yield). HRMS (ESI/CH2Cl2) m / z calcd for C22H28N2O5Na (M + Na)
+: 
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423.1896, found 423.1888.  1HNMR (500 MHz, CDCl3) δ 7.31–7.23 (m, 10H), 7.26 (br, s, 2H) 
4.43 (d, J = 5.0 Hz, 4H) 3.92 (s, 4H) 3.50 (s, 8H). 13CNMR (125 MHz, CDCl3) δ 169.8, 138.2, 
128.7, 127.8, 127.5, 70.8, 70.4, 70.0, 42.8. IR (film) 3030.1, 2913.0, 1656.8, 1529.8, 1496.6, 
1454.0, 1102.6, 1028.5 cm-1. 
2-methoxy-1-(piperidin-1-yl)ethan-1-one. (Table 2.1, Entry 11) The general procedure for 
Table 2.1 was followed using . [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol 
%), KOH (8.2 mg, 0.15 mmol, 15 mol %), 2-methoxyethanol (76 mg, 1.0 mmol, 1.0 equiv.), 
piperidine (85 mg, 1.0 mmol, 1.0 equiv.) toluene (1 mL). The product was purified via flash 
chromatography with EtOAc and hexanes (1:4) to give clear oil (135 mg, 86% isolated yield). 
HRMS (ESI/CH2Cl2) m / z calcd for C8H15NO2Na (M + Na)
+:180.1001, Found: 180.0997. HNMR 
(500 MHz, CDCl3) δ 4.10 (m, 2H), 3.55 (m, 2H) 3.42 (s, 3H), 3.39 (m, 2H), 1.65 (m, 2H), 1.57 
(m, 4H). 13CNMR (125 MHz, CDCl3) δ 167.3, 59.0, 46.00, 42.9, 26.5, 25.6, 24.5. IR (film) 2926.3, 
2854.6, 1644.6, 1466.0, 1117.7 cm-1. 
Morpholino(phenyl)methanone. (Table 2.1, Entry 12) The general procedure for Table 2.1 was 
followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), KOH (8.2 
mg, 0.15 mmol, 15 mol %), morpholine (87 mg, 1.0 mmol, 1.0 equiv.), benzylalcohol (108 mg, 
1.0 mmol, 1.0 equiv.), and toluene (1 mL). The product was purified via flash chromatography 
with EtOAc and hexanes (1:4) to give a clear oil (164 mg, 86% isolated yield). 1HNMR (500 MHz, 
CDCl3) δ 7.42 - 7.39 (m, 5H), 3.75–3.45 (m, 8H) ppm. 13CNMR (125 MHz, CDCl3) δ 170.5, 135.3, 
129.9, 128.6, 127.1, 66.9 (2 carbons) ppm. The physical data were identical in all respects to those 
previously reported. 43 
N-benzyl-2-methoxy-N-methylacetamide. (Table 2.1, Entry 13) The general procedure for 
Table 2.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol 
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%), KOH (8.2 mg, 0.15 mmol, 15 mol %), N-methylbenzylamine (121 mg, 1.0 mmol, 1.0 equiv.), 
2-methoxyethanol (76 mg, 1.0 mmol, 1.0 equiv.), and toluene (1 mL). The product was purified 
via flash chromatography with EtOAc and hexanes (1:4) to give a clear oil (164 mg, 88% isolated 
yield). Due to constrained rotational nature of the tertiary amide, product is a mixture of two 
rotamers (A: major, B: minor) in a 60:40 A:B ratio. NMR experiments at 350K showed 
coalescence of the two rotamer peaks. 1HNMR (500 MHz, CDCl3) δ 7.42-7.24 (m, 5H)[A][B], 
4.65 (s, 2H)[A], 4.58 (s, 2H)[B], 4.21 (s, 2H)[A], 4.20 (s, 2H)[B], 3.52 (s, 3H)[A], 3.48 (s, 3H)[B], 
2.99 (s, 3H)[B], 2.94 (s, 3H)[A] ppm. 13CNMR (125 MHz, CDCl3) δ 169.4 [B], 169.1 [A], 137.0 
[A], 136.3 [B], 129.0 [A], 128.7 [A], 128.2 [A], 127.8 [B], 127.5 [B], 126.6 [B], 71.6 [B], 71.5 
[A], 59.3 [B], 59.2 [A], 52.5 [B], 51.0 [A], 33.7 [B], 33.6 [A] ppm. The physical data were identical 
in all respects to those previously reported. 44 
N-benzyl-N-ethyl-2-methoxyacetamide. (Table 2.1, Entry 14) The general procedure for Table 
2.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), 
KOH (8.2 mg, 0.15 mmol, 15 mol %), N-ethylbenzylamine (136 mg, 1.0 mmol, 1.0 equiv.), 2-
methoxyethanol (76 mg, 1.0 mmol, 1.0 equiv.), and toluene (1 mL). The product was purified via 
flash chromatography with EtOAc and hexanes (1:4) to give a  white solid (113 mg, 55% isolated 
yield). Due to constrained rotational nature of the tertiary amide, product is a mixture of two 
rotamers (A: major, B: minor) in a 60:40 A:B ratio. NMR experiments at 350K in DMSO-d6 
showed coalescence of the two rotamer peaks.  HRMS (ESI/CH2Cl2) m / z calcd for C12H17NO2Na 
(M + Na)+:230.1157. Found [M + Na]+: 230.1148.  1HNMR (500 MHz, CDCl3) δ 7.36-7.22 (m, 
5H)[A][B], 4.61 (s, 2H)[A], 4.52 (s, 2H)[B], 4.18 (s, 2H)[A], 4.11 (s, 2H)[B], 3.48 (s, 3H)[A], 
3.42 (s, 2H)[B], 3.41 (q, J = 6.5 Hz, 2H)[B], 3.25 (q, J = 6.5 Hz, 2H)[A], 1.14 (t, J = 6.5 Hz, 
2H)[A], 1.11 (t, J = 6.5 Hz, 2H)[B]. 13CNMR (125 MHz, CDCl3) δ 169.0 [B], 169.0 [A], 137.5 
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[A], 136.8 [B], 129.0 [A], 128.6 [A], 128.2 [A], 127.7 [B], 127.4 [B], 126.6 [B], 71.7 [B], 71.4 
[A], 59.3 [A], 59.3 [B], 49.7 [B], 47.7 [A], 40.9 [B], 40.6 [A], 13.7 [A], 12.6 [B] ppm. IR (film) 
3033.1, 2924.2, 1644.0, 1452.0, 1431.9, 1134.8, 1109.4, 1080.5 cm-1. 
N,N-dibenzyl-2-methoxyacetamide. (Table 2.1, Entry 15) The general procedure for Table 2.1 
was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), KOH 
(8.2 mg, 0.15 mmol, 15 mol %), dibenzylamine (294 mg, 1.5 mmol, 1.5 equiv.), 2-methoxyethanol 
(76 mg, 1.0 mmol, 1.0 equiv.), xylene (1 mL). Reaction was heated at reflux for 24 h. Excess 
amine extracted by dissolving compound in EtOAc and washing with 3 x 50 mL 1 M HCl. The 
product was purified via flash chromatography with EtOAc and hexanes (1:4) to give a clear oil 
(94 mg, 35% isolated yield). HRMS (ESI/CH2Cl2) m / z calcd for C17H19NO2Na (M + Na)
+: 
292.1313, Found: 292.1323. 1HNMR (500 MHz, CDCl3) δ 7.37–7.15 (m, 10H), 4.59 (s, 2H) 4.43 
(s, 2H) 4.20 (s, 2H) 3.46 (s, 3H) ppm. 13CNMR (125 MHz, CDCl3) δ 169.5, 136.9, 136.1, 129.0, 
128.6, 128.4, 127.7, 127.5, 126.6, 71.5, 59.3, 48.9, 47.9. IR (film) 3028.8, 2919.4, 1649.9, 1450.9, 
1429.3, 1195.8, 1128.3, 1106.4, 1080.2 cm-1. 
N-benzylcyclohexanamine. (Table 2, Entry 1) The general procedure for Table 2.2 was followed 
using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), KOH (8.2 mg, 0.15 
mmol, 15 mol %), cyclohexanol (100 mg, 1.0 mmol, 1.0 equiv.), benzylamine (107 mg, 1.0 mmol, 
1.0 equiv.), and toluene (1 mL). The remaining mixture is purified via flash chromatography using 
EtOAc and hexanes (1:1) to give a tan oil (158 mg, 85% isolated yield). 1HNMR (500 MHz, 
CDCl3) δ 7.32-7.19 (m, 5H) 3.81 (s, 2H), 1.93-1.89 (m, 2H), 1.75-1.70 (m, 2H), 1.65-1.59 (m, 
1H), 1.44 (s, 1H), 1.33-1.00 (m, 6H) ppm. 13CNMR (125 MHz, CDCl3) δ 140.9, 128.3, 127.9, 
126.7, 56.1, 51.0, 33.5, 26.1, 24.9. The physical data were identical in all respects to those 
previously reported. 45 
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N-benzyl-1,1-diphenylmethanamine. (Table 2, Entry 2) The general procedure for Table 2.1 
was followed using . [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), KOH 
(8.2 mg, 0.15 mmol, 15 mol %), diphenylmethanol (184 mg, 1.0 mmol, 1.0 equiv.), benzylamine 
(107 mg, 1.0 mmol, 1.0 equiv.), and toluene (1 mL). The remaining mixture is purified via flash 
chromatography using EtOAc and hexanes (1:1) to give white solid (139 mg, 85% isolated yield). 
1HNMR (500 MHz, CDCl3) δ 7.49-7.22 (m, 15H) 4.88 (s, 1H), 3.78 (s, 2H), 1.89 (s, 1H) ppm. 
13CNMR (125 MHz, CDCl3) δ 144.0, 140.5, 128.5, 128.5, 128.2, 127.4, 127.1, 127.0, 66.5, 51.9 
ppm. The physical data were identical in all respects to those previously reported. 45 
N-benzylpentan-3-amine. (Table 2, Entry 3) The general procedure for Table 2.2 was followed 
using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), KOH (8.2 mg, 0.15 
mmol, 15 mol %), 3-pentanol (87 mg, 1.0 mmol, 1.0 equiv.), benzylamine (107 mg, 1.0 mmol, 1.0 
equiv.), and toluene (1 mL). The remaining mixture is purified via flash chromatography using 
EtOAc and hexanes (1:1) to give a tan oil (71 mg, 40% isolated yield). 1HNMR (500 MHz, CDCl3) 
δ 7.37− 7.20 (m, 5H), 3.74 (s, 2H), 2.41 (q, J = 6.0 Hz, 1H) 1.59 (s, 1H), 1.52−1.40 (m, 4H), 0.87 
(t, J = 6.0 Hz, 6H) ppm. 13CNMR (125 MHz, CDCl3) δ 141.3, 128.7, 128.5, 127.1, 59.7, 51.5, 
26.0, 10.2 ppm. The physical data were identical in all respects to those previously reported. 46 
N-benzyl-1-phenylethan-1-amine. (Table 2, entry 4) The general procedure for Table 2.2 was 
followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol %), KOH (8.2 
mg, 0.15 mmol, 15 mol %), 1-phenylethan-1-ol (122 mg, 1.0 mmol, 1.0 equiv.), benzylamine (107 
mg, 1.0 mmol, 1.0 equiv.), and toluene (1 mL). The remaining mixture is purified via flash 
chromatography using EtOAc and hexanes (1:1) to give a tan oil (168 mg, 80% isolated yield). 
1HNMR (500 MHz, CDCl3) δ 7.48 – 7.22 (m, 10H), 3.85 (q, J = 6.5 Hz, 1H), 3.70 (d, J = 13.0 Hz, 
1H) 3.61 (d, J = 13.0 Hz, 1H), 1.70 (s, 1H), 1.39 (d, J = 6.5 Hz, 3H) ppm. (125 MHz, CDCl3) δ 
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145.6, 140.7, 128.6, 128.4, 128.2, 127.0, 126.9, 126.7, 57.5, 51.7, 24.5 ppm. The physical data 
were identical in all respects to those previously reported.45  
N-benzyl-1,2,3,4-tetrahydronaphthalen-1-amine. (Table 2, Entry 5) The general procedure for 
Table 2.2 was followed using  [RuHCl(CO)(HN(CH2CH2PPh2)2)] (4) (6.0 mg, 0.01 mmol, 1 mol 
%), KOH (8.2 mg, 0.15 mmol, 15 mol %), 1,2,3,4-tetrahydronaphthalen-1-ol (148 mg, 1.0 mmol, 
1.0 equiv.), benzylamine (107 mg, 1.0 mmol, 1.0 equiv.), and toluene (1 mL, 1M). The remaining 
mixture is purified via flash chromatography using EtOAc and hexanes (1:20) to give tan oil (94 
mg, 40% isolated yield). 1HNMR (500 MHz, CDCl3) δ 7.60-7.24 (m, 9H), 4.10 (d, J = 13.0 Hz, 
1H), 4.00 (d, J = 13.0 Hz, 1H), 3.95 (t, J = 5.0 Hz, 1H), 3.04-2.84 (m, 2H), 2.24-2.04 (m, 3H) 1.94-
1.85 (m, 1H). 1.54 (s, 1H) ppm. 13CNMR (125 MHz, CDCl3) 142.2, 139.5, 137.7, 129.3, 129.0, 
128.5, 128.3, 127.0, 126.8, 125.9, 54.9, 51.4, 29.6, 28.4, 19.3 ppm. The physical data were 
identical in all respects to those previously reported. 45 
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N,N'-(1,4-phenylenebis(methylene))bis(2-methoxyacetamide)
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2-methoxy-1-(piperidin-1-yl)ethan-1-one 
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N-benzyl-N-ethyl-2-methoxyacetamide
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N,N-dibenzyl-2-methoxyacetamide
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Chapter 3 : From Racemic Alcohols to Enantiopure Amines: Ru-Catalyzed 
Diastereoselective Amination 
Abstract: A commercially available ruthenium(II) PNP-type pincer catalyst (Ru-Macho) 
promotes formation of α-chiral tert-butanesulfinylamines from racemic secondary alcohols and 
Ellman’s chiral tert-butanesulfinamide via a hydrogen borrowing strategy. The formation of α-
chiral tert-butanesulfinylamines occurs in yields ranging from 31% to 89% with most examples 
giving >95:5 dr. 
3.1 Introduction:  
Due to the high value of α-chiral amines in 
both medicinal and synthetic chemistry, there is a 
need to develop more efficient methods for the 
stereoselective construction of C–N bonds.1, 2 
Since its discovery in 1997, Ellman’s sulfinamide 
has become a widely used reagent for the synthesis 
of α-chiral primary amines, with many industrially 
relevant applications.3, 4  Considering the high practicality of this sulfinamide as an ammonia 
equivalent, we sought a catalytic method for the diastereoselective N-alkylation of Ellman’s 
sulfinamide 1 using readily available secondary alcohols 2 (Figure 3.1).5-7 This formal nucleophilic 
substitution would transform racemic alcohols into enantiopure amines and generate water as the 
only byproduct.  Herein, we describe a Ru-catalyzed approach that overcomes the need for 
stoichiometric reagents and achieves in a single operation what traditionally requires three 
chemical steps (i.e, oxidation, condensation using Ti(OEt)4, and then reduction) as shown in Figure 
3.1. 
Figure 3.1 Diastereoselective Amination: Proposed 
catalytic strategy (one-step) versus conventional approach 
(three-steps) 
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The direct amination of alcohols has 
been demonstrated with various catalysts,8-13 
but only one single stereoselective amination 
has been achieved to date by Zhao and 
coworkers.14   This Ir-catalyzed method is 
limited, however, to the synthesis of chiral 
anilines.14  Guided by previous studies using 
Ru-pincer complexes,5, 15-21 we proposed that 
racemic alcohol 2 (Figure 3.2) would undergo 
oxidation by Ru-pincer complex 3a to form ketone 4 and Ru-hydride 3b.  The ketone 4 would 
undergo condensation with sulfinamide 1 to form the sulﬁnylimine 5.22-24 Hydrogenation of imine 
5 via Ru-hydride 3b would proceed with high and predictable diastereoselectivity to generate the 
α-chiral sulfinylamine 6.22-24 To achieve this novel alkylation, we recognized the challenge of 
identifying a catalyst that would favor hydrogen-transfer over competing pathways (e.g. 
acceptorless dehydrogenation).25-36 Moreover, the Ru-catalyst would need to tolerate H2O as the 
main byproduct. 
3.2 Results and Discussion: 
 To test our hypothesis, we investigated the coupling of 1 and racemic alcohol 1-
phenylethanol (2b) with a number of Ru-pincer complexes (Table 3.1). A few structurally related 
pincer-complexes, including Milstein’s catalyst (Table 3.1, entry 1), as well as two catalysts 
developed by the Gusev group (entries 2, 3) showed no desired reactivity, even though these 
catalysts are known to activate both C–N and C–O bonds.25, 37-39 In a previous study,40 we 
discovered that Ru-Macho41 acted as an efficient catalyst for the dehydrogenative synthesis of 
Figure 3.2 Mechanistic proposal featuring hydrogen borrowing 
via a ruthenium(II) pincer complex 
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amides and imines from alcohols and amines. 
We envisioned that this complex could 
potentially act as a hydrogen-transfer catalyst to 
afford the desired product. Indeed, Ru-Macho 
afforded α-chiral sulfinylamine 6 in 71% 
isolated yield (entry 4).  By further tuning the 
reaction parameters, we identified the optimal 
conditions to be the use of toluene as solvent 
and KOH as base, at 120 °C (89%, entry 10). 
The transformation occurs efficiently using 
only 1 mol % catalyst loadings. 
 With this protocol in hand, we transformed a 
range of racemic alcohols into optically active 
amines. (Table 3.2).42  The reaction conditions 
do not epimerize the chiral sulfinamide and the 
expected enantiomer was afforded after 
coupling with an achiral alcohol (entry 1). Both 
electron donating and electron withdrawing groups on the β-phenyl group relative to the amine 
could be incorporated (entries 3–7, 73–89% yield, >95:5 dr). Fluorine-containing amines were 
obtained in good yields (73–89%) with high diastereocontrol (>95:5 dr) (entries 5 and 6). Next, 
we found that chiral pyridinyl derivatives (6h–j) could be generated in 55–80% isolated yields, 
with high diastereoselectivity (>95:5 dr) (entries 8–10). A racemic alcohol bearing a larger 
aromatic substituent, such as the 2-napthyl group (entry 11) undergoes coupling in 84% yield and 
Table 3.1 Optimization of reaction conditions for the formation 
of N-tert-butanesulfinylamines 
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>95:5 dr (entry 12). When the aryl group was substituted for saturated hydrocarbon chains (Table 
3.2, entries 12 and 13), a drop in diastereoselectivity (75:25 and 70:30 dr respectively) was 
observed, but the reaction yield remained between 71–81% (6l, m). Our observation is in 
agreement with previous studies by Ellman and others who found that reduction of sulﬁnylimines 
proceeds with lowered diastereocontrol when the β-substituents are similar in size.3, 43-45 In entries 
12 and 13, we propose that the lower diastereocontrol is due to the similar steric bulk of a methyl 
group and an n-butyl or (-(CH2)2Ph) group.
18 In contrast, an alcohol with a β-i-Pr group (entry 14) 
was shown to form the corresponding sulﬁnylamine with higher diastereoselectivity (>95:5) due 
to a greater difference in the steric bulk (6n).19    
Table 3.2 Variation of secondary alcohols used in diastereoselective amination 
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 The synthesis of α-chiral amines bearing a β-methyl 
group is challenging to achieve due to low 
diastereocontrol in the conventional use of MeLi to 
add to N-tert-butylsulﬁnylaldimine.3, 4  In contrast, our 
method is most effective for the construction of amines 
bearing a β-methyl group  (entries 2–15). Ru-Macho 
appears sensitive to the steric bulk at the β-position on 
the sulfinylimine intermediate during hydrogen-transfer (Figure 3.2, 5). For example, lower 
isolated yields were encountered when bulkier groups were placed in the β-position on both sides 
of the alcohol (entries 15–16) (31–36%), but diastereoselectivities remained high (>95:5 dr) (6o–
p). We found that more bulky substrates, (e.g., a tert-butyl substituted alcohol or ortho-arylated 
alcohol) shows no reactivity under these conditions (entries 17 and 18).  
3.3 Conclusion: 
In summary, this study provides an effective method for chiral amine synthesis by 
combining the power of the widely used Ellman’s sulfinamide auxiliary with the practicality of 
the inexpensive and industrially relevant Ru-Macho catalyst.41 By using a hydrogen borrowing 
strategy, α-chiral amines can be accessed directly from racemic alcohols in one step.8-12  In addition 
to fewer required steps, this catalytic approach overcomes the need for use of stoichiometric Lewis 
acids.3, 4 Moreover, the resulting diastereomeric products can be easily separated.3, 4 Importantly, 
this methodology enables access to methyl-substituted chiral amines that are challenging to obtain 
with methyl organometallic reagents.3, 4 Ongoing studies to expand substrate scope via catalyst 
design are underway. 
 
Figure 3.3 Proposed transition state for the catalytic 
transformation 
57 
 
 
3.4 Supporting Information 
General Information: For experiments involving the glovebox, we used nitrogen 
atmosphere in a Vacuum Atmospheres Company Glove box and vials that were sealed under a 
nitrogen atmosphere. Toluene was purchased from Fisher Chemical and purged with argon for 2 
hours and then dried by passing it through two columns of neutral alumina under argon pressure. 
Dioxane, DMF, DMSO, chlorobenzene, xylene, and DMF were purchased from Aldrich Chemical 
Co or Ficher Chemical and purged with nitrogen for 30 minutes before use.  Alcohols were used 
as received from Aldrich Chemical Co or Ficher Chemical after being purged with nitrogen for 30 
minutes. Some alcohols were prepared via reduction of the corresponding ketone with sodium 
borohydride in methanol.3 (R)-(+)-2-methyl-2-propanesulfinamide was used as received from 
Combi-Blocks. [RuHCl(CO)(HN(CH2CH2PPh2)2)] (Ru-Macho catalyst) was purchased from 
Strem Chemicals Inc. and used as received. Milstein’s Catalyst was used as purchased from Strem 
Chemicals Inc. The SNS and PNN Gusev catalysts were used as received from Aldrich Chemical 
Co. KOH was purchased from Fisher Chemical and then grounded with a mortar and pestle (in the 
glovebox) to a fine powder and stored in the glovebox. Column chromatography was performed 
using a Teledyne Isco CombiFlash Rf 200c with Gold high performance HP Silica 
Chromatography columns from Teledyne and the solvent scheme indicated.  
General Analytical Information: All new compounds (6c, 6e, 6k) were characterized by 
1H NMR, 13C NMR, ESI-MS, IR, and optical rotation. NMR spectra were obtained using Bruker 
500 MHz instruments. All 1H NMR and 13C NMR are reported in ppm relative to TMS (0.00 ppm) 
unless otherwise noted. IR spectra were obtained using a Thermo Scientific Nicolet iS5 iD5 ATR 
IR spectrometer. GC-MS (CI) was performed using a GCT Premier Micromass MS Technologies 
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mass spectrometer, coupled with a Waters 7890A gas chromatograph. ESI-MS was performed 
using a LCT Premier Micromass MS Technologies mass spectrometer. Optical rotation was 
obtained using a Rudolph Research Analytical Autopol III Automatic Polarimeter. For known 
compounds, we have cited the published characterization data that we used to compare to our 
synthesized compounds and we have included a 1H NMR spectrum to establish purity of the 
isolated material. 
General Procedure for Examples in Table 3.1: An oven dried 1 dram vial equipped with 
a stir bar was brought into  a nitrogen filled glove box. The vial was charged with indicated catalyst 
(0.01 mmol, 1 mol %), indicated base (0.15 mmol, 15 mol %), (R)-(+)-2-methyl-2-
propanesulfinamide (61 mg, 0.5 mmol, 1.0 equiv.), 1-phenylethanol (61 mg, 0.5 mmol, 1.0 equiv.), 
and the indicated solvent (1 mL) in that order. After all reagents were  added to the vial, the vial 
was sealed with a PTFE cap, electrical tape, and then removed from the glove box. The reaction 
vessel was heated at 110 °C in a silicone oil bath for 8 h and the resulting mixture allowed to cool 
to rt. Diastereomeric ratio was determined by 1H NMR analysis of the unpurified reaction mixture. 
The peak used to determine diastereomeric ratios are noted with an asterisk and the range where 
the two diastereomeric peaks appear is shown with their respective integrations.    
General Procedure for Examples in Table 3.2: An oven dried 5 mL conical vial equipped 
with a stir bar was brought a nitrogen filled glove box. The vial was charged with 
[RuHCl(CO)(HN(CH2CH2PPh2)2)] (6.0 mg, 0.01 mmol, 1 mol %), KOH (8.2 mg, 0.15 mmol, 15 
mol %), (R)-(+)-2-methyl-2-propanesulfinamide (61 mg, 0.5 mmol, 1.0 equiv.), alcohol (0.5 
mmol, 1.0 equiv.), and toluene (1 mL) in that order. After all reagents have been added to the vial, 
the vial was sealed with a PTFE cap, electrical tape, and then removed from the glove box. The 
reaction vessel was heated at the indicated temperature in a silicone oil bath for 6-12 h and then 
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allowed to cool to rt. Diasteromeric ratio was determined by 1H NMR analysis of the unpurified 
reaction mixture. For products 6c, 6e, and 6k, the optical purity wasestablished by removal of the 
tert-butylsulfinyl group to yield the chiral amine. After purification, the optical rotation of the 
resulting amine was compared to literature standards via polarimetry. Removal of the tert-
butylsulfinyl group was performed according to previous literature procedures.4 The amines were 
purified using flash chromatography with the indicated solvent system. 
Synthesis and Characterizations of Compounds: 
(R)-N-cyclohexyl-2-methylpropane-2-sulfinamide (6a). The general procedure for Table 3.1 
was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 mmol, 1 mol%), KOH (4.1 
mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide (61 mg, 0.5 mmol, 1.0 
equiv.) cyclohexanol (50 mg, 0.5 mmol, 1.0 equiv.) and toluene (1 mL). The reaction vessel was 
heated for 12 h in a silicone oil bath at 120 °C. The crude product was purified via flash 
chromatography with EtOAc in Hexanes (gradient from 0% to 100% EtOAc) to give a white solid 
(95.6 mg, 85% isolated yield, >95% ee. 1H NMR (500 MHz, CDCl3) δ 3.21 (m, 1H), 2.98 (br, s, 
1H), 2.01–1.92 (m, 2H), 1.75–1.62 (m, 2H), 1.65–1.53 (m, 1H), 1.39–1.09 (m, 5H), 1.19 (s, 9H) 
ppm. 13C NMR (125 MHz, CDCl3) δ 55.5, 54.5, 35.5, 34.4, 25.8, 25.1, 24.7, 22.8 ppm. [α]D24.1 = 
-92.5° (c = 1.0, CH3Cl). All spectroscopic data match previously reported values.
46 
(R)-2-methyl-N-((R)-1-phenylethyl)propane-2-sulfinamide (6b). The general procedure for 
Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 mmol, 1 mol%), 
KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide (61 mg, 0.5 mmol, 
1.0 equiv.), sec-phenylethylalcohol (61 mg, 0.5 mmol, 1.0 equiv.) and toluene (1 mL). The reaction 
vessel was heated for 7 h in a silicone oil bath at 120 °C. The crude product was purified via flash 
chromatography with EtOAc in Hexanes (gradient from 0% to 100% EtOAc) to give a colorless 
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oil (95.6 mg, 85% isolated yield, >95:5 dr (R,R : R,S)). 1H NMR (500 MHz, CDCl3) δ 7.36-7.27 
(m, 5H), 4.59-4.51 (m, 1H), 3.43* (br, s, 1H), 1.51 (d, J = 5.0 Hz, 3H), 1.24 (s, 9H) ppm. 13C NMR 
(125 MHz, CDCl3) δ 144.1, 128.8, 127.9, 126.7, 55.5, 53.9, 22.8, 22.7 ppm. All spectroscopic data 
match previously reported values.43 
(R)-N-((R)-1-(3-chlorophenyl)ethyl)-2-methylpropane-2-sulfinamide (6c). The general 
procedure for Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 
mmol, 1 mol%), KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide 
(61 mg, 0.5 mmol, 1.0 equiv.), 1-(3-chlorophenyl)ethan-1-ol (78 mg, 0.5 mmol, 1.0 equiv.) and 
toluene (1 mL). The reaction vessel was heated for 6 h in a silicone oil bath at 120 °C. The crude 
product was purified via flash chromatography with EtOAc in Hexanes (gradient from 0% to 100% 
EtOAc) to give a colorless oil (103 mg, 79% isolated yield, >95:5 dr (R,R : R,S)). HRMS 
(ESI/MeOH) m/z calcd for C12H18ClNOS (M + Na)
+: 282.0695, Found: 282.0687. 1H NMR (500 
MHz, CDCl3) δ 7.45 – 7.10 (m, 4H), 4.56-4.48 (m, 1H), 3.41* (br, s, 1H), 1.50 (d, J = 6.5 Hz, 3H), 
1.24 (s, 9H) ppm. 13C NMR (125 MHz, CDCl3) δ 146.2, 134.7, 130.2, 128.2, 126.9, 125.1, 55.7, 
53.7, 22.9, 22.7 ppm. IR (film) 3210.4, 3155.5, 3057.9, 2975.9, 2954.9, 2921.1, 2864.9, 1594.8, 
1573.3, 1433.5, 1389.1, 1362.2, 1329.2, 1306.1, 1258.1, 1205.3, 1052.7 cm-1. The  optical purity 
was deduced by the optical rotation of the corresponding chiral amine using a polarimeter. The 
chiral amine was obtained through treatment of the reaction mixture with HCl after heating the 
reaction for the specified time to remove the N-tertbutanesulfinyl group. Optical rotation of (R)-
(+)-1-(3-chlorophenyl)ethan-1-amine [α]D24.3 = +27.1° (c = 1.2, MeOH). All spectroscopic data 
match previously reported values of the amine product.24 
(R)-N-((R)-1-(4-bromophenyl)ethyl)-2-methylpropane-2-sulfinamide (6d). The general 
procedure for Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 
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mmol, 1 mol%), KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide 
(61 mg, 0.5 mmol, 1.0 equiv.), 1-(4-bromophenyl)ethan-1-ol (100 mg, 0.5 mmol, 1.0 equiv.) and 
toluene (1 mL). The reaction vessel was heated for 12 h in a silicone oil bath at 120 °C. The crude 
product was purified via flash chromatography with EtOAc in Hexanes (gradient from 0% to 100% 
EtOAc) to give a tan oil (114.1 mg, 75% isolated yield, >95:5 dr (R,R : R,S)). 1H NMR (500 MHz, 
CDCl3) δ 7.48 (d, J = 8.5 Hz, 2H), 7.23 (d, J = 8.5 Hz, 2H), 4.55-4.47 (m, 1H), 3.38* (br, s, 1H), 
1.50 (d, J = 5.0 Hz, 3H), 1.23 (s, 9H) ppm. 13C NMR (125 MHz, CDCl3) δ 143.1, 131.9, 128.4, 
121.7, 55.6, 53.6, 22.8, 22.6 ppm. All spectroscopic data match previously reported values.43 
(R)-N-((R)-1-(4-fluorophenyl)ethyl)-2-methylpropane-2-sulfinamide (6e). The general 
procedure for Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 
mmol, 1 mol%), KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide 
(61 mg, 0.5 mmol, 1.0 equiv.), 1-(4-fluorophenyl)ethan-1-ol (70 mg, 0.5 mmol, 1.0 equiv.) and 
toluene (1 mL). The reaction vessel was heated for 6 h in a silicone oil bath at 120 °C. The crude 
product was purified via flash chromatography with EtOAc in Hexanes (gradient from 0% to 100% 
EtOAc) to give a colorless oil (107 mg, 89% isolated yield, >95:5 dr (R,R : R,S)). HRMS 
(ESI/MeOH) m/z calcd for C12H18FNOS (M + Na)
+: 266.0991, Found: 266.0989. 1H NMR (500 
MHz, CDCl3) δ 7.42 – 7.34 (m, 2H), 7.08 (t, J = 8.6 Hz, 2H), 4.63-4.55 (m, 1H), 3.45 (br, s, 1H), 
1.55 (d, J = 6.6 Hz, 3H), 1.29 (s, 9H). 13C NMR (125 MHz, CDCl3) δ 163.3, 161.3, 139.9, 128.4, 
128.3, 115.7, 115.6, 76.9, 55.6, 53.5, 22.9, 22.7 ppm. IR (film) 3207.5, 2975.2, 2928.5, 2868.7, 
1602.9, 1509.4, 1478.5, 1455.7, 1363.6, 1220.9, 1051.1 cm-1. The  optical purity was measured by 
optical rotation of the corresponding chiral amine using a polarimeter. The chiral amine was 
obtained through treatment of the reaction mixture with HCl after heating the reaction for the 
specified time to remove the N-tert-butane sulfinyl group. Optical rotation of α-(R)-(+)-p-
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fluorophenylethylamine [α]D24.3 = +24.6° (c = 1.0, MeOH). All spectroscopic data match 
previously reported values of the amine product.47 
(R)-2-methyl-N-((R)-1-(4-(trifluoromethyl)phenyl)ethyl)propane-2-sulfinamide (6f). The 
general procedure for Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 
0.05 mmol, 1 mol%), KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-
propanesulfinamide (61 mg, 0.5 mmol, 1.0 equiv.), 1-(4-(trifluoromethyl)phenyl)ethan-1-ol (95 
mg, 0.5 mmol, 1.0 equiv.) and toluene (1 mL). The reaction vessel was heated for 12 h in a silicone 
oil bath at 120 °C. The crude product was purified via flash chromatography with EtOAc in 
Hexanes (gradient from 0% to 100% EtOAc) to give a colorless oil (107 mg, 73% isolated yield, 
>95:5 dr (R,R : R,S)). 1H NMR (500 MHz, CDCl3) δ 7.61 (d, J = 8.0 Hz, 2H), 7.48 (d, J = 7.9 Hz, 
2H), 4.65-4.57 (m, 1H), 3.46* (s, 1H), 1.53 (d, J = 6.6 Hz, 3H), 1.25 (s, 9H) ppm. 13C NMR (126 
MHz, CDCl3) δ 148.0, 129.9 (q, J = 30.5 Hz) 127.0, 125.8 (q, J = 4.0 Hz), 122.2, 55.7, 53.8, 22.9, 
22.6 ppm. All spectroscopic data match previously reported values.43 
(R)-N-((R)-1-(4-methoxyphenyl)ethyl)-2-methylpropane-2-sulfinamide (6g). The general 
procedure for Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 
mmol, 1 mol%), KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide 
(61 mg, 0.5 mmol, 1.0 equiv.), 1-(4-methoxyphenyl)ethan-1-ol (76 mg, 0.5 mmol, 1.0 equiv.) and 
toluene (1 mL). The reaction vessel was heated for 10 h in a silicone oil bath at 120 °C. The crude 
product was purified via flash chromatography with EtOAc in Hexanes (gradient from 0% to 100% 
EtOAc) to give a colorless oil (63.7 mg, 50% isolated yield, >95:5 dr (R,R : R,S)). 1H NMR (500 
MHz, CDCl3) δ 7.27 (d, J = 9.0 Hz, 2H) 6.88 (d, J = 9.0 Hz, 2H), 4.55-4.47 (m, 1 H), 3.80 (s, 3H), 
3.34* (br, s, 1H), 1.49 (d, J = 5.0 Hz, 3H), 1.23 (s, 9H) ppm. 13C NMR (125 MHz, CDCl3) δ 159.2, 
63 
 
136.3, 127.8, 114.1, 55.4, 55.3, 53.4, 22.8, 22.7 ppm. All spectroscopic data match previously 
reported values.43 
(R)-2-methyl-N-((R)-1-(pyridin-3-yl)ethyl)propane-2-sulfinamide (6h). The general procedure 
for Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 mmol, 1 
mol%), KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide (61 mg, 
0.5 mmol, 1.0 equiv.), 1-(pyridin-3-yl)ethan-1-ol (61.5 mg, 0.5 mmol, 1.0 equiv.) and toluene (1 
mL). The reaction vessel was heated for 7 h in a silicone oil bath at 120 °C. The crude product was 
purified via flash chromatography with EtOAc in Hexanes (gradient from 0% to 100% EtOAc) to 
give a colorless oil (90.4 mg, 80% isolated yield, >95:5 dr (R,R : R,S)). 1H NMR (500 MHz, 
CDCl3) δ 8.61 (s, 1H), 8.55 (d, J = 3.5 Hz, 1H), 7.70 (d, J = 7.8 Hz, 1H), 7.34 – 7.24 (m, 1H), 
4.63-4.55 (m, 1H), 3.51* (br, s, 1H), 1.56 (d, J = 6.6 Hz, 3H), 1.24 (s, 9H) ppm. 13C NMR (125 
MHz, CDCl3) δ 149.3, 148.4, 139.4, 134.4, 123.7, 55.7, 52.1, 22.8, 22.6 ppm. All spectroscopic 
data match previously reported values.44 
(R)-2-methyl-N-((R)-1-(pyridin-2-yl)ethyl)propane-2-sulfinamide (6i). The general procedure 
for Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 mmol, 1 
mol%), KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide (61 mg, 
0.5 mmol, 1.0 equiv.), 1-(pyridin-2-yl)ethan-1-ol (61 mg, 0.5 mmol, 1.0 equiv.) and toluene (1 
mL). The reaction vessel was heated for 6 h in a silicone oil bath at 120 °C. The crude product was 
purified via flash chromatography with EtOAc in Hexanes (gradient from 0% to 100% EtOAc) to 
give a colorless oil (62 mg, 55% isolated yield, >95:5 dr (R,R : R,S)). 1H NMR (500 MHz, CDCl3) 
δ 8.56 (d, 1H, J = 4.8 Hz), 7.68 (dt, 1H, J = 7.8, 1.5 Hz), 7.30 (d, 1H, J = 7.5 Hz), 7.21 (dd, 1H, J 
= 5.0, 2.0 Hz), 4.85 (br, s, 1H), 4.66–4.55 (m, 1H), 1.51* (d, 3H, J = 6.5 Hz), 1.26 (s, 9H). 13C 
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NMR (126 MHz, CDCl3) δ 161.8, 149.0, 136.8, 122.3, 121.0, 55.6, 55.2, 23.3, 22.7 ppm. All 
spectroscopic data match previously reported values.44 
(R)-2-methyl-N-((R)-1-(pyridin-4-yl)ethyl)propane-2-sulfinamide (6j). The general procedure 
for Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 mmol, 1 
mol%), KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide (61 mg, 
0.5 mmol, 1.0 equiv.), 1-(pyridin-4-yl)ethan-1-ol (61 mg, 0.5 mmol, 1.0 equiv.) and toluene (1 
mL). The reaction vessel was heated for 6 h in a silicone oil bath at 120 °C. The crude product was 
purified via flash chromatography with EtOAc in Hexanes (gradient from 0% to 100% EtOAc) to 
give a colorless oil (83 mg, 74% isolated yield, >95:5 dr (R,R : R,S)). 1H NMR (500 MHz, CDCl3) 
δ 8.58 (d, J = 5.5 Hz, 2H), 7.29 (d, J = 5.5 Hz, 2H), 4.59–4.49 (m, 1H), 3.65* (br, s, 1H), 1.52 (d, 
J = 6.1 Hz, 3H), 1.25 (s, 9H) ppm. 13C NMR (126 MHz, CDCl3) δ 152.7, 149.9, 121.5, 55.7, 53.3, 
22.5, 22.4 ppm. All spectroscopic data match previously reported values.44 
(R)-2-methyl-N-((R)-1-(naphthalen-2-yl)ethyl)propane-2-sulfinamide (6k). The general 
procedure for Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 
mmol, 1 mol%), KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide 
(61 mg, 0.5 mmol, 1.0 equiv.), 1-(naphthalen-2-yl)ethan-1-ol (76 mg, 0.5 mmol, 1.0 equiv.) and 
toluene (1 mL). The reaction vessel was heated for 6 h in a silicone oil bath at 120 °C. The crude 
product was purified via flash chromatography with EtOAc in Hexanes (gradient from 0% to 100% 
EtOAc) to give a colorless solid (115 mg, 84% isolated yield, >95:5 dr (R,R : R,S)). HRMS 
(ESI/MeOH) m/z calcd for C16H21NOS (M + Na)
+: 298.1241 Found: 298.1231 . 1H NMR (500 
MHz, CDCl3) δ 7.84 – 7.75 (m, 4H), 7.53 – 7.38 (m, 3H), 4.84 – 4.61 (m, 1H), 3.50* (br, s, 1H), 
1.61 (d, J = 6.1 Hz, 3H), 1.26 (s, 9H) ppm. 13C NMR (126 MHz, CDCl3) δ 141.45, 133.45, 133.15, 
128.80, 128.10, 127.82, 126.45, 126.22, 125.49, 124.85, 55.66, 54.16, 22.78, 22.75 ppm. IR (film) 
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3294.3, 3253.9, 3055.2, 3016.4, 2978.7, 2955.3, 2926.4, 2898.7, 2865.3, 1601.1, 1507.85, 1471.2 
1385.1, 1358.5, 1058.0 cm-1. The optical purity was measured by the optical rotation of the 
corresponding chiral amine using a polarimeter. The chiral amine was obtained through treatment 
of the reaction mixture with HCl after heating the reaction for the specified time to remove the N-
tert-butanesulfinyl group. Optical rotation of (R)-(+)-1-(naphthalen-2-yl)ethan-1-amine [α]D24.3 = 
+19.6° (c = 1.0, MeOH). All spectroscopic data match previously reported values of the amine 
product.48 
(R)-2-methyl-N-((R)-4-phenylbutan-2-yl)propane-2-sulfinamide (6l). The general procedure 
for Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 mmol, 1 
mol%), KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide (61 mg, 
0.5 mmol, 1.0 equiv.), 1 4-phenylbutan-2-ol (75 mg, 0.5 mmol, 1.0 equiv.) and toluene (1 mL). 
The reaction vessel was heated for 12 h in a silicone oil bath at 120 °C. The crude product was 
purified via flash chromatography with EtOAc in Hexanes (gradient from 0% to 100% EtOAc) to 
give a colorless oil (90.4 mg, 75% isolated yield, 75:25 dr (R,R : R,S)). 1H NMR (500 MHz, 
CDCl3) δ 7.28 – 7.14 (m, 5H), 3.43 (m, 1H), 3.09* (br, s, 1H), 2.71 (m, 2H), 1.98 – 1.74 (m, 2H), 
1.23 (d, J = 6.4 Hz, 3H), 1.19 (s, 9H) ppm. 13C NMR (125 MHz, CDCl3) δ 141.6, 128.5, 128.5, 
126.0, 55.4, 51.1, 40.0, 32.2, 22.6, 21.7 ppm. All spectroscopic data match previously reported 
values.43 
(R)-N-((R)-hexan-2-yl)-2-methylpropane-2-sulfinamide (6m). The general procedure for Table 
3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 mmol, 1 mol%), KOH 
(4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide (61 mg, 0.5 mmol, 1.0 
equiv.), 2-hexanol (51 mg, 0.5 mmol, 1.0 equiv.) and toluene (1 mL). The reaction vessel was 
heated for 10 h in a silicone oil bath at 120 °C. The crude product was purified via flash 
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chromatography with EtOAc in Hexanes (gradient from 0% to 100% EtOAc) to give a tan oil (83.5  
mg, 81% isolated yield, 99:1 dr (R,R : R,S)). 1H NMR (500 MHz, CDCl3) δ 3.41-3.32 (m, 1H), 
3.03* (br, s, 1H), 1.61-1.41 (m, 2H), 1.35-1.30 (m, 4H), 1.19 (s, 9H), 1.15 (d, J = 8.0, 3H), 0.91 
(m, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 55.1, 51.2, 38.1, 27.9, 22.5, 22.4, 21.3, 13.9 ppm. 
All spectroscopic data match previously reported values.45 
(R)-2-methyl-N-((R)-3-methylbutan-2-yl)propane-2-sulfinamide (6n). The generalprocedure 
for Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 mmol, 1 
mol%), KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide (61 mg, 
0.5 mmol, 1.0 equiv.), 3-methyl-butan-2-ol (44 mg, 0.5 mmol, 1.0 equiv.) and toluene (1 mL). The 
reaction vessel was heated for 6 h in a silicone oil bath at 120 °C. The crude product was purified 
via flash chromatography with EtOAc in Hexanes (gradient from 0% to 100% EtOAc) to give a 
colorless oil (56 mg, 59% isolated yield, >95:5 dr (R,R : R,S)). 1H NMR (500 MHz, CDCl3) δ 3.38 
– 3.29 (m, 1H), 3.24* (br, s, 1H), 1.82 (qt, J = 13.8, 6.8 Hz, 1H), 1.27 (d, J = 11.1 Hz, 9H), 1.15 
(d, J = 6.5 Hz, 3H), 0.97 (dd, J = 15.7, 8.0 Hz, 6H) ppm. 13C NMR (126 MHz, CDCl3) δ 55.8, 
34.0, 22.6, 18.8, 17.2, 16.8 ppm. All spectroscopic data match previously reported values.45 
(R)-2-methyl-N-((R)-1,2,3,4-tetrahydronaphthalen-1-yl)propane-2-sulfinamide (6o). The 
general procedure for Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 
0.05 mmol, 1 mol%), KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-
propanesulfinamide (61 mg, 0.5 mmol, 1.0 equiv.), 1,2,3,4-tetrahydronaphthalen-1-ol (76 mg, 0.5 
mmol, 1.0 equiv.) and toluene (1 mL). The reaction vessel was heated for 6 h in a silicone oil bath 
at 120 °C. The crude product was purified via flash chromatography with EtOAc in Hexanes 
(gradient from 0% to 100% EtOAc) to give a brown oil (43.9 mg, 36% isolated yield, >95:5 dr 
(R,R : R,S)). 1H NMR (500 MHz, CDCl3) δ 7.47 (dd, J = 5.0 , 3.5 Hz, 1H), 7.24-7.16 (m, 2H), 
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7.09 (dd, J = 5.0, 3.5 Hz, 1H), 4.58-4.55 (m, 1H), 3.21* (d, J = 2.5 Hz, 1H), 2.89-2.65 (m, 2H), 
2.05-1.83 (m, 3H), 1.80-1.73 (m, 1H), 1.20 (s, 9H) ppm. 13C NMR (125 MHz, CDCl3) δ 137.8, 
136.7, 129.7, 129.3, 127.6, 126.6, 55.5, 52.8, 30.6, 29.1, 22.7, 18.2 ppm. All spectroscopic data 
match previously reported values.45 
(R)-2-methyl-N-((R)-1-phenylpropyl)propane-2-sulfinamide (6p). The general procedure for 
Table 3.1 was followed using [RuHCl(CO)(HN(CH2CH2PPh2)2)] (3.0 mg, 0.05 mmol, 1 mol%), 
KOH (4.1 mg, 0.075 mmol, 15 mol %), (R)-(+)-2-methyl-2-propanesulfinamide (61 mg, 0.5 mmol, 
1.0 equiv.), 1-phenyl-1-propanol (68 mg, 0.5 mmol, 1.0 equiv.) and toluene (1 mL). The reaction 
vessel was heated for 12 h in a silicone oil bath at 120 °C. The crude product was purified via flash 
chromatography with EtOAc in Hexanes (gradient from 0% to 100% EtOAc) to give a colorless 
oil (38.4 mg, 32% isolated yield, >95:5 dr (R,R : R,S)). 1H NMR (500 MHz, CDCl3) δ 7.39 – 7.21 
(m, 5H), 4.33 – 4.20 (m, 1H), 3.53* (br, s, 1H), 2.09 – 1.99 (m, 1H), 1.86 – 1.66 (m, 1H), 1.23 (s, 
9H), 0.80 (t, J = 7.4 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 142.3, 128.7, 127.9, 127.3, 60.6, 
55.8, 29.4, 22.7, 10.1. All spectroscopic data match previously reported values.43 
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1H NMR spectrum of 6b (CDCl3, 25° C) 
 
1H and 13C NMR spectra of 6c (CDCl3, 25° C) 
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1H and spectra of 6d (CDCl3, 25° C) 
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1H and 13C NMR spectra of 6e (CDCl3, 25° C) 
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1H spectrum of 6f (CDCl3, 25° C) 
 
1H spectrum of 6g (CDCl3, 25° C) 
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1H spectrum of 6h (CDCl3, 25° C) 
 
1H spectrum of 6i (CDCl3, 25° C) 
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1H spectrum of 6j (CDCl3, 25° C) 
 
1H spectrum of 6k (CDCl3, 25° C) 
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1H and 13C NMR spectra of 6l (CDCl3, 25° C) 
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1H spectrum of 6m (CDCl3, 25° C) 
 
1H spectrum of 6n (CDCl3, 25° C) 
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1H spectrum of 6o (CDCl3, 25° C) 
 
1H spectrum of 6p (CDCl3, 25° C) 
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1H NMR of reaction mixture used for dr calculations 
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Chapter 4 : Biodegradable Dendronized Polymers for Efficient mRNA Delivery 
Abstract: As chemically modified messenger RNAs become less immunogenic and more stable 
against RNases, the need for synthetic vectors that can efficiently deliver mRNA into cells has 
increased significantly. Based on a dendronized polypeptide (denpol) architecture, we describe 
here the development of a synthetic vector system for efficient delivery of mRNAs. The optimized 
denpols show high efficiency of mRNA delivery to a variety of cells including primary murine 
dendritic cells (BMDCs), giving it potential use for anti-tumor immunotherapy. 
4.1 Introduction: 
Originally thought to be too unstable and immunogenic for the treatment of diseases, 
messenger RNA (mRNA) has reemerged as a promising therapeutic for cancers, vaccines, and 
stem-cell therapy.1-5 In accordance, the demand and applicability for synthetic vectors tailored to 
mRNA delivery has also increased greatly.6-8 Much like other nucleic acids, mRNA is a large 
anionic polymer and does not readily pass through the cell membrane unassisted.8 However, since 
mRNA only requires delivery to the cellular cytoplasm, it avoids the drawbacks of protein 
expression via plasmid DNA (pDNA) or viral vector delivery (e.g. insertive mutagenesis, delivery 
to nucleus.)  Recently, synthetic vectors such as liposomes3, 6, 9-13 and cationic polymers,4, 14-22 
many of which were originally developed for pDNA or siRNA delivery, as well as physical 
delivery methods,8, 23-26 have been used to deliver mRNA to the cytoplasm for various applications. 
Nevertheless, mRNA delivery is significantly understudied compared to siRNA and pDNA 
delivery methods.8   
As a notable application, mRNA–based prophylactic and therapeutic antitumor immunity 
has vitalized the field of immuno-oncology. Peptide or protein antigens isolated from tumors are 
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coded into mRNA and delivered ex vivo or in vivo 
to dendritic cells. Upon translation of the mRNA, 
major histocompatibility complexes (MHC) 
present the coded antigen and activate T-cells 
against the tumor.27 Liposomes and cationic 
polymers are currently used for this application, 1, 
6-8, 10  but inefficient delivery to immune cells is 
hindering further clinical applications.1, 27, 28 On 
closer inspection, some of the synthetic mRNA 
delivery vectors were found to be reformulated or 
modified based on siRNA or pDNA delivery 
vectors. While the repurposed materials showed 
some efficacy, there was little discussion about 
what specific variables or changes were important for effective mRNA delivery. Based on a 
dendronized polymer system our lab previously created for siRNA delivery,29 herein we report 
biodegradable polymeric vectors for efficient delivery of mRNA to various cells (Figure 4.1A). 
We investigated key factors that contribute to increased mRNA delivery with a specific goal to 
improve transfections in immune cells.  
4.2 Results and Discussion: 
 The dendronized polypeptide (denpol) system initially developed by our lab for siRNA 
delivery29 contains an L-lysine- dicysteine polymer backbone having multiple lysine dendrons  
grown on the surface to achieve a vector combining the conformational flexibility of a linear 
polymer and the beneficial multivalent interactions of a dendrimer (Figure 4.1). Additionally, the 
Figure 4.1 Concept and general structure of Denpol for 
mRNA delivery. 
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disulfide linkages in the polymer backbone can be reduced inside the cellular cytoplasm and acts 
as a selective release mechanism. The initial report of denpol demonstrated that surface 
functionalization of the lysine dendrons with histidine (His) and tryptophan (Trp) was vital for 
effective siRNA delivery. Histidine provides the buffering capacity needed to escape the endosome 
during lysosomal maturation, and the indole ring of Trp binds the nucleic acids via π-stacking and 
improves cellular uptake.29 The optimal vector obtained for siRNA delivery contained a G2 lysine 
dendron functionalized with a 3:1 ratio of His:Trp. For the purpose of mRNA delivery, several 
structural parameters were varied to optimize the performance. First, given the less ordered 
secondary structure of single stranded mRNA compared to double stranded siRNA, we 
hypothesized a higher generation lysine dendron or additional Trp may be required to effectively 
complex and deliver mRNA. Therefore, denpols containing G2 or G3 lysine dendrons 
functionalized with higher amounts of tryptophan were studied. Second, we envisioned that the 
long anionic mRNA might increase aggregation during nanoparticle assembly with denpol. To 
prevent this from occurring, denpols functionalized with either short tetraethylene glycol (TEG) 
or long polyethylene glycol (PEG2K, Mn=2000 Da) units on the backbone were investigated. 
 The synthesis of the denpols was completed in the same manner as previously reported 
using conventional peptide coupling chemistry and a “graft-from” approach (for a detailed 
synthesis scheme and characterization details see the supporting information 4.4, Figure 4.13.)29 
Figure 4.1B shows a generalized G2 denpol structure, where the R1 group can either be a lysine 
dendron or a TEG/PEG group, and the R2 group can either be a His or Trp.  A series of denpols 
were synthesized by varying the amount of TEG/PEG and the His:Trp molar ratio. For example, 
G2 25 TEG 3:1 represents a denpol that has 75 mol% G2 lysine dendrons and 25 mol% TEG on 
the backbone, and 75 mol% His 25 mol% Trp (3:1 ratio of His:Trp) functionalized on the surface 
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of the lysine dendrons (as determined by 1HNMR).  Figure 4.5 represents the complete family of 
denpols made and used in the study. His:Trp ratios of 3:1, 2:1, 1:1, 1:2 and 1:3 were targeted for 
functionalization to the G2 and G3 lysine dendrons. Results from the initial transfections (vida 
infra) were used to select denpol vectors for further study. 
 The non-PEGylated G2 and G3 denpols were tested first to determine if a higher generation 
or more Trp had a positive effect on transfection ability.  To assay mRNA delivery, NIH 3T3 cells 
were treated with a firefly luciferase (FLuc, 5-methylcytidine, pseudouridine modified) 
mRNA/denpol nanoplex. Fifteen hours after transfection, D-Luciferin was added, and 
luminescence was measured with an IVIS camera. Lipofectamine MessengerMax (LF MM) was 
used as a positive control. Naked mRNA with no delivery vector and untreated cells were used as 
negative controls. The initial transfection conditions used were based on those optimized for 
siRNA transfections.  The vector was used starting at an N:P ratio of 45 (molar ratio of protonated 
amines of the vector to phosphates of the mRNA). To form nanoparticles, 200 ng of mRNA 
solution was added directly to a 10 mg/mL solution of the vector and mixed via pipette. The 
mixture was then diluted to a final volume with OptiMEM and mixed again with a pipette before 
incubation with the cells. The G2 denpols produced luminescence comparable to the positive 
control, whereas the G3 denpols were largely ineffective (Figure 4.2A).  Interestingly, higher 
luminescence was observed when decreasing the His:Trp ratio from 3:1 to 2:1, but quickly drops 
off in efficiency when approaching 1:1, suggesting an optimal ratio of ~ 2:1. When the ratio is 
decreased to 1:2 or 1:3, the vectors become cytotoxic and ineffective (Figure 4.5), therefore only 
ratios of 3:1, 2:1, or 1:1 were used for further studies. We hypothesize delivery efficiency decreases 
and toxicity increases as tryptophan increases past 1:1 because the denpol becomes too 
hydrophobic to bind mRNA and may disrupt the cell membrane. 
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 Notably, the 
PEGylated denpols show 
excellent serum tolerance for 
mRNA delivery. When 
denpol and mRNA were 
complexed and then added to 
complete media (10% fetal 
bovine serum (FBS) in 
OptiMEM) instead of buffer 
alone, a universal increase in 
transfection efficiency was 
observed (Figure 4.6). Based 
on this observation, the rest 
of the study was completed 
using at least 10% FBS. 
Increasing the amount of FBS to 80% in the transfection media had little or no effect on the 
transfection ability of the PEGylated denpols, but drastically diminished the efficacy of the non-
PEGylated denpols (Figure 4.7). Presumably, PEGylation reduces nonspecific interactions with 
serum components and enhances the colloidal stability for the mRNA complexes. 
 To find out the optimal formulation for mRNA delivery, differing N:P ratios for the 
PEGylated and non-PEGylated denpols were tested via transfection to find the optimal N:P ratio 
for mRNA delivery. Luminescence was greatest for the PEGylated denpols surveyed between 5-
15 N:P, drastically reducing the amount of vector needed for mRNA transfections compared to 
Figure 4.2 Transfection of 3T3 cells with denpols (70% confluence, 24 h exposure to 
transfection media, 200 ng Fluc mRNA per well). A) Screen of the His:Trp ratio for 
non-PEGylated denpols (N:P = 45). B) Screen of the denpol library created for study. 
(N:P = 10)  * = P < 0.01, ** = P < 0.001 
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siRNA transfections (Figure 4.8). This was further confirmed using gel shift assays, which showed 
that all denpols bound mRNA by an N:P of 5 (Figure 4.9). Luminescence of non-PEGylated 
denpols plateaued after an N:P of 10 and did not increase at higher N:P ratios. Luminescence of 
PEGylated denpols peaked between an N:P of 10-15 and then decreased when more than the 
optimal amount of denpol was used (Figure 4.8).  
 After optimized conditions had been identified (10% FBS, N:P 10) the denpols were all 
tested against each other to find the best vectors (Figure 4.2B, Figure 4.10 shows all vectors 
screened). In general, the vectors containing a His:Trp ratio of 2:1 and G2 lysine dendron gave the 
highest expression.  G2 50 TEG 2:1 had the highest luminescence of the vectors measured. 
Excitingly, the best denpol vector is much more effective for delivering mRNA into cells, 
exhibiting 10 folds increase in luminescence compared to the positive control (LF MM). No 
cytotoxicity was observed via lactate dehydrogenase (LDH) assay, except for the vectors with a 
His:Trp ratio below 1:2 as mentioned above (Figure 4.5). Further transfection studies were 
performed using cyanine 5 (cy-5) mRNA in conjunction with flow cytometry to examine cellular 
uptake and the percentage of cells with mRNA associated. Ideally, a synthetic mRNA vector would 
induce high amounts of mRNA association in 100% of the cells intended for delivery. Indeed, the 
most effective vectors were able to associate mRNA to a majority of the cells (>70% contained 
cy-5 labeled mRNA, Figure 4.2B) with the best vectors associating over 90% of cells. 
 Dynamic light scattering (DLS) was used to examine the size and zeta potential of the 
denpol nanoparticles. DLS in PBS showed that the effective non-PEGylated nanoparticles (G2 2:1 
and G2 3:1) initially formed nanoparticles in the 100 – 200 nm range (Figure 4.3A) but aggregated 
over time (Figure 4.11). The PEGylated denpols formed stable nanoparticles between 100 – 200 
nm and did not aggregate with time. G3 denpols tended to aggregate quickly and form cloudy 
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precipitates, which could not be 
measured via DLS. Atomic force 
microscopy (AFM) was used to 
confirm nanoparticle size (Figure 
4.12). Zeta potential measurements 
in PBS revealed negatively charged 
particles. The DLS data and 
transfection data agrees with the 
knowledge that nanoparticles in the 
50 – 200 nm size range are generally 
optimal for cellular uptake.30 The 
DLS measurements in combination 
the transfection results agree with 
our initial hypothesis that mRNA is 
more prone to aggregation during 
formulation compared to siRNA (e.g., G2 3:1 does not aggregate when formulated with siRNA)29. 
Accordingly, when TEG/PEG was functionalized to the backbone, colloidal stability was regained, 
and transfection efficiency increased.   
 Confocal microscopy using cy-5 labeled FLuc mRNA was used to visualize internalization 
of the denpol/mRNA nanoparticles (Figure 4.3B). Images of the G3 denpols shows large clusters 
of nanoparticles on the surface of the cells and aggregates on the floor of the well, but shows little 
internalization (Figure 4.3B). TEG/PEGylated G2 denpol/mRNA complexes showed more 
dispersed nanoparticles. There were no obvious differences between the  3:1 and  2:1 denpols when  
Figure 4.3 Denpol nanoparticle characterization. N:P = 10 A) Diameter is 
based on Z-Avg in PBS. Zeta potential measurements are in PBS B) Confocal 
microscopy image highlighting a colloidally stable (G2 50 TEG 2:1) denpol 
versus a denpol that aggregates (G3 3:1). White bar represents 20 μm. 
96 
 
examined. The confocal 
images corroborate the DLS 
results, as one can visually see 
the large aggregates from the 
G3 denpols are not able to 
enter the cellular endosome or 
cytoplasm, and thus 
inefficiently deliver mRNA. 
 As discussed in the 
introduction, the delivery of 
antigen coding mRNA to 
dendritic cells can excite T 
cell activity against tumors; 
however, nucleic acid 
delivery to dendritic cells is 
notorious for being 
inefficient.1, 6-8, 10  Given the 
high efficiency of denpol for mRNA delivery to 3T3 cells, the denpol system was tested in 
immortalized murine dendritic cells (DC 2.4) cells to confirm if transfection would be operative 
in an immune cell line. Using the transfection conditions optimized in 3T3 cells, it was observed 
that the same denpols that were active in 3T3 cells were also active in DC 2.4 (Figure 4.4A). Again, 
the most effective denpol showed ~ 10 fold higher GFP expression than the positive control (LF 
MM). Flow cytometry using GFP mRNA showed that for the most effective denpol vectors a 
Figure 4.4 Transfections in dendritic cells 
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majority of cells (~70%) were GFP positive. After confirming that denpol was effective to deliver 
mRNA into DC 2.4 cells, further transfections using primary murine bone marrow derived, 
dendritic cells (BMDCs) ex vivo were attempted. The best denpols tested transfected ~60% of the 
BMDCs expressed GFP and provided significant production of GFP after only one treatment 
(Figure 4.4B). Additionally, the successful delivery of both GFP (996 nucleotides) and FLuc (1929 
nucleotides) mRNA shows that denpol can efficiently accommodate mRNA of different length. 
The high efficiency of delivery to both DC 2.4 and BMDC cells demonstrates the promise of 
denpol vectors for further studies of mRNA-based vaccination. 
4.3 Conclusion: 
In conclusion, we have developed a denpol vector system that is highly efficient for mRNA 
delivery to various cells.  Through the study, we identified several important factors for designing 
effective mRNA delivery vectors. The study first demonstrated that increasing the amount of 
tryptophan on the dendron surface increases transfection efficiency, presumably due to the 
increased binding to the less ordered structure of mRNA. Then, we showed TEG/PEGylation 
increased transfection ability, serum tolerance, and colloidal stability of the denpol/mRNA 
nanoparticles by reducing the propensity of mRNA for aggregation. Finally, denpol was 
demonstrated to transfect both DC2.4 and BMDCs at high efficiency, showing great promise for 
future investigations with mRNA adjuvanting. Further studies on both new designs of denpol 
vectors and biological applications of mRNA delivery are currently underway in our laboratory.   
4.4 Supplementary Information: 
General Information: Unless otherwise noticed, all reagents were used as received from 
commercial suppliers without further purification. Protected amino acids were purchased from 
Advanced ChemTech (Loiusville, KY) and Aroz Technologies, LLC. (Cincinnati, OH). Coupling 
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reagents were purchased from GL Biochem Ltd. (Shanghai, China).  FLuc mRNA (5meC, Ψ), 
Cyanine 5 FLuc mRNA (5meC, Ψ), and Cyanine 5 EGFP mRNA (5meC, Ψ) were obtained from 
TriLink Biotechnologies (Sorrento Mesa, CA). Lipofectamine MessangerMAX was purchased 
from Invitrogen (Carlsbad, CA). Pierce™ LDH Cytotoxicity Assay Kit was purchased from 
ThermoFisher (San Jose, CA). All reactions were performed using HPLC grade solvent unless 
otherwise noted.  All water used in biological experiments was nanopure water obtained from 
Barnstead Nanopure Diamond (Waltham, MA). Unmodified NIH 3T3 cells were a generous gift 
from Professor Young Jik Kwon (Department of Chemical Engineering, UC Irvine, CA). 
Unmodified DC 2.4 cells and BMDCs were a generous gift from Professor Aaron Esser-Kahn’s 
lab (Department of Chemistry, UC Irvine, CA). The BMDCs were harvested according to the 
procedure outlined in “Stimulation of Innate Immune Cells by Light-activated TLR7/8 Agonists” 
(IACUC protocol # 2012-3048).31 Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine 
serum (FBS), and OptiMEM were purchased from Invitrogen (Carlsbad, CA). 
General Analytical Information: The molecular weight and molecular weight 
distribution of the Denpol backbone was measured by gel permeation chromatography (GPC). 
1HNMR spectra were obtained using 500 and 600 MHz Bruker instruments. 1 HNMR chemical 
shifts were reported as values in ppm relative to deuterated solvents indicated. GPC was performed 
on an Agilent 1100 SEC system using a OHpak SB-803 HQ column from Shodex. The molecular 
weight was determined with respect to poly(ethylene glycol) (PEG) S3 standards purchased from 
Aldrich. DMF with 0.1% LiBr (wt/v) was used as the eluent at a flow rate of 1.0 mL/min with 
column temperature at 45°C. The size and zeta potential of denpol/mRNA polyplexes were 
measured at 633 nm using Zetasizer (NanoZS) dynamic light scattering instrument (Malvern 
Instruments, Malvern, UK) at 25 ˚C with detection angle of 173˚. Confocal images were obtained 
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using a Ziess LSM 700 (Carl Zeiss AG, Oberkochen, Germany). Flow cytometry was performed 
on a BD ACCURI C6 flow cytometer (BD Biosciences, San Jose). AFM images were all taken on 
an MFP-3D StandAlone AFM (Asylum Research, Santa Barbara, CA) through tapping-mode 
using a monolithic silicon TESP-10 tip (NanoAndMore USA, Watsonville, CA) with resonant 
frequency =320 kHz and a spring constant k =42 N/m. 
Supplementary Figures: 
 
Figure 4.5 Cytotoxicity of the denpol vectors against 3T3 cells assayed using a LDH assay 
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Figure 4.6 Effect of 10% FBS on denpol transfections 
 
Figure 4.7 Effects of increasing FBS concentration in transfection efficiency. N:P = 10, 200 ng  FLuc mRNA, 24 hours exposure 
to transfection media. 
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Figure 4.8 Representative N:P screen of a non-PEGylated and PEGylated vector. Non-PEGylated vectors tended to plateau after 
N:P 10 and had slightly diminished luminescence after N:P 30.  PEGylated vectors Peaked between N:P 5 – 15 and had a 
maximum at N:P 10. 
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Figure 4.9 Representative gel shift binding assays in 1% agarose. All vectors surveyed bound mRNA by N:P 5. 
 
Figure 4.10 Complete screen of all denpols made 
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Figure 4.11 Aggregation of non-PEG/TEGylated polymers over time 
 
Figure 4.12 Dry AFM of G2 1.5 PEG2k 2:1 mRNA denpol nanoparticles on mica. Each side represents 5 μm. 
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Synthesis of Denpols (DP): 
 
Figure 4.13 General synthetic scheme for Denpol.  Amounts of NHS-PEG-OMe and dendron on the surface of the denpol backbone 
are specified in the procedures. 
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Typical procedure for Denpol functionalization: 
In a 1 dram vial equipped with a stir bar, the specified DP (10.0 mg, 1.00 equiv) was dissolved in 
1 mL of DMF. After the denpol backbone was completely dissolved, Boc-His(Boc)-OH, and Boc-
Trp(Boc)-OH were added in the corresponding ratios.  After all reagents had been solubilized, 
PyBOP (10.00 equiv.) and DIPEA (12.00 equiv.) were added, and the 1 dram vial was sealed with 
nitrogen and stirred over-night.  After 12 h, 3 mL of MeOH was added to the reaction, and the 
mixture was purified via dialysis (MWCO = 6 – 8 kD) against MeOH for 12 h.  After 12 h the 
mixture was concentrated in vacuo (no heating), yielding a solid film.  The Boc groups were 
removed by suspending the solid in a mixture of TFA (1.5 mL), DCM (0.75 mL), anisole (0.75 
mL), and TIPS (0.1 mL) and stirring for 4 h under nitrogen.  The mixture was concentrated in 
vacuo (no heating), resuspended in methanol, and then precipitated in cold ether.  The precipitate 
was pelleted via centrifugation, and the supernatant was discarded.  The precipitate was purified 
via dialysis (MWCO = 6 – 8 kD) against MeOH for 24 h and then concentrated in vacuo.  All 
denpols were characterized by 1H NMR. The final functionalization ratio was calculated using the 
same methodology as previously reported.29 
Histidine Tryptophan functionalized G2 Denpols: 
See procedure for typical denpol functionalization  
G2 3:1 (77.4 H 22.6 W): Boc-His(Boc)-OH (6.00 equiv.) and Boc-Trp(Boc)-OH (2.00 equiv.). 
Clear colorless solid. 71% isolated yield.   
G2 2:1 (66 H 34 W): Boc-His(Boc)-OH (4.80 equiv.) and Boc-Trp(Boc)-OH (3.20 equiv.). Clear 
colorless solid. 62% isolated yield.    
G2 1:1 (55 H 45 W): Boc-His(Boc)-OH (4.00 equiv.) and Boc-Trp(Boc)-OH (4.00 equiv.). Clear 
colorless solid. 89% isolated yield.    
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G2 1:2 (39 H 61 W): Boc-His(Boc)-OH (3.20 equiv.) and Boc-Trp(Boc)-OH (4.80 equiv.). Clear 
colorless solid. 78% isolated yield.    
G2 1:3 (27 H 73 W): Boc-His(Boc)-OH (2.00 equiv.) and Boc-Trp(Boc)-OH (6.00 equiv.). Clear 
colorless solid. 74% isolated yield 
Denpol G3 backbone 
G3 backbone In a 25 mL RB flask equipped with a stir bar, DP G2 (76.3 mg, 1.00 equiv, 0.037 
mmol) was dissolved in 4 mL of DMF. After the denpol backbone was completely dissolved, Boc-
Lys(Boc)-OH DCHA was added.  After all reagents had been solubilized, PyBOP (191.1 mg, 10.00 
equiv., 0.37 mmol) and DIPEA (103.4 μL, 12.00 equiv., 0593 mmol) were added, and the flask 
was sealed with nitrogen and stirred over-night.  After 12 h, 8 mL of MeOH was added to the 
reaction, and the mixture was purified via dialysis (MWCO = 6 – 8 kD) against MeOH for 12 h.  
After 12 h the mixture was concentrated in vacuo (no heating), yielding a solid film.  The Boc 
groups were removed by suspending the solid in a mixture of TFA (3.0 mL), DCM (1.5 mL), 
anisole (1.5 mL), and TIPS (0.2 mL) and stirring for 4 h under nitrogen.  The mixture was 
concentrated in vacuo (no heating), suspended in methanol, and then precipitated in cold diethyl 
ether.  The precipitate was pelleted via centrifugation, and the supernatant was discarded.  The 
precipitate was purified via dialysis (MWCO = 6 – 8 kD) against MeOH for 24 h and then 
concentrated in vacuo. Clear colorless solid. 93% isolated yield.  
Histidine Tryptophan functionalized G3 Denpols: 
See procedure for typical denpol functionalization. 
G3 3:1 (71 H 29 W): Boc-His(Boc)-OH (12.00 equiv.) and Boc-Trp(Boc)-OH (4.00 equiv.). Clear 
colorless solid. 93% isolated yield.    
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G3 2:1 (66 H 34 W): Boc-His(Boc)-OH (9.60 equiv.) and Boc-Trp(Boc)-OH (6.40 equiv.). Clear 
colorless solid. 91% isolated yield.  
G3 1:1 (53 H 47 W): Boc-His(Boc)-OH (8.00 equiv.) and Boc-Trp(Boc)-OH (8.00 equiv.). Clear 
colorless solid. 82% isolated yield.     
G3 1:2 (33 H 67 W): Boc-His(Boc)-OH (6.40 equiv.) and Boc-Trp(Boc)-OH (9.60 equiv.). Clear 
colorless solid. 78% isolated yield.  
G3 1:3 (28 H 72 W): Boc-His(Boc)-OH (4.00 equiv.) and Boc-Trp(Boc)-OH (12.00 equiv.). Clear 
colorless solid. 86% isolated yield.  
G1 TEG Backbones: 
NHS-TEG-OMe and NHS-PEG2k-OMe was prepared according to previous literature.32 
Typical procedure for functionalization of denpol G0 backbone with TEG or PEG: 
In a 25 mL RB flask equipped with a stir bar, DP backbone (50 mg, 1.00 equiv., 0.083 mmol) was 
dissolved in 4 mL of DMF and DIPEA (57.6 μL, 5.00 equiv., 0.330 mmol) was added.  The 
reaction was cooled to 0°C and the NHS-TEG-OMe or NHS-PEG-OMe was added in the 
corresponding amount. The flask was sealed with nitrogen and stirred for 4 h. After stirring, Boc-
Lys(Boc)-OH DCHA (86.6 mg, 2.00 equiv., 0.165 mmol) and PyBOP (128.9 mg, 3.00 equiv. 
0.248 mmol) are added. After 12 h, 8 mL of MeOH was added to the reaction, and the mixture 
was purified via dialysis (MWCO = 6 – 8 kD) against MeOH for 12 h.  After 12 h the mixture was 
concentrated in vacuo (no heating), yielding a solid film.  The Boc groups were removed by 
suspending the solid in a mixture of TFA (3.0 mL), DCM (1.5 mL), anisole (1.5 mL), and TIPS 
(0.2 mL) and stirring for 4 h under nitrogen.  The mixture was concentrated in vacuo (no heating), 
resuspended in methanol, and then precipitated in cold diethyl ether.  The precipitate was pelleted 
via centrifugation, and the supernatant was discarded.  The precipitate was purified via dialysis 
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(MWCO = 6 – 8 kD) against MeOH for 24 h and then concentrated in vacuo. % TEG or PEG 
functionalization was determined via 1H NMR. % functionalization represents % of TEG or PEG 
per SRU. The compounds are named to represent which polymer (TEG or PEG) is functionalized 
off the backbone and in what percent.   
G1 25 TEG: (23% by NMR) NHS-TEG-OMe (20.6 mg, 0.50 equiv., 0.0415 mmol). Clear 
colorless solid. 81% isolated yield.  
G1 50 TEG: (42% by NMR) NHS-TEG-OMe (41.1 mg, 1.0 equiv., 0.083 mmol). Clear colorless 
solid. 68% isolated yield.   
G1 75 TEG: (62% by NMR) NHS-TEG-OMe (61.7 mg, 1.50 equiv., 0.124 mmol). Clear 
colorless solid. 83% isolated yield.   
G2 TEG Backbones: 
Typical Procedure for synthesis of G2 lysine dendrons on the TEGylated (or PEG) DP backbones: 
In a 25 mL RB flask equipped with a stir bar, DPBBTEG G1 (1.00 equiv) was dissolved in DMF. 
After the DPBBTEG G1 was completely dissolved, Boc-Lys(Boc)-OH DCHA (4.00 equiv) was 
added.  After all reagents had been solubilized, PyBOP (6.00 equiv.) and DIPEA (8.00 equiv.) 
were added, and the flask was sealed with nitrogen and stirred over-night.  After 12 h, 8 mL of 
MeOH was added to the reaction, and the mixture was purified via dialysis (MWCO = 6 – 8 kD) 
against MeOH for 12 h.  After 12 h the mixture was concentrated in vacuo (no heating), yielding 
a solid film.  The Boc groups were removed by suspending the solid in a mixture of TFA (3.0 mL), 
DCM (1.5 mL), anisole (1.5 mL), and TIPS (0.2 mL) and stirring for 4 h under nitrogen.  The 
mixture was concentrated in vacuo (no heating), resuspended in methanol, and then precipitated 
in cold diethyl ether.  The precipitate was pelleted via centrifugation, and the supernatant was 
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discarded.  The precipitate was purified via dialysis (MWCO = 6 – 8 kD) against MeOH for 24 h 
and then concentrated in vacuo.  
G2 TEG 25: Clear colorless solid. 93% isolated yield.  
G2 TEG 50: Clear colorless solid. 91% isolated yield.  
G2 TEG 75: Clear colorless solid. 88% isolated yield.  
Histidine Tryptophan functionalized TEG G2 Denpols: 
See procedure for typical DP functionalization. 
G2 25 TEG 3:1 (74 H 26 W): Boc-His(Boc)-OH (4.62 equiv.) and Boc-Trp(Boc)-OH (1.54 
equiv.). Clear colorless solid. 59% isolated yield.  
G2 25 TEG 2:1 (63 H 32 W): Boc-His(Boc)-OH (4.01 equiv.) and Boc-Trp(Boc)-OH (2.16 
equiv.). Clear colorless solid. 87% isolated yield.  
G2 50 TEG 3:1 (73 H 27 W): Boc-His(Boc)-OH (3.48 equiv.) and Boc-Trp(Boc)-OH (1.16 
equiv.). Clear colorless solid. 85% isolated yield.  
G2 50 TEG 2:1 (64 H 36 W): Boc-His(Boc)-OH (3.02 equiv.) and Boc-Trp(Boc)-OH (1.62 
equiv.). Clear colorless solid. 71% isolated yield.  
G2 75 TEG 3:1 (71 H 29 W): Boc-His(Boc)-OH (2.28 equiv.) and Boc-Trp(Boc)-OH (0.76 
equiv.). Clear colorless solid. 85% isolated yield.  
G2 75 TEG 2:1 (61 H 39 W): Boc-His(Boc)-OH (1.98 equiv.) and Boc-Trp(Boc)-OH (1.06 
equiv.). Clear colorless solid. 77% isolated yield 
G3 TEG Backbones: 
Typical Procedure for synthesis of G3 lysine dendrons on the TEGylated DP backbones: 
In a 25 mL RB flask equipped with a stir bar, DPBBTEG G2 (1.00 equiv.) was dissolved in DMF. 
After the DPBBTEG G2 was completely dissolved, Boc-Lys(Boc)-OH DCHA (8.00 equiv.) was 
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added.  After all reagents had been solubilized, PyBOP (10.00 equiv.) and DIPEA (12.00 equiv.) 
were added, and the flask was sealed with nitrogen and stirred over-night.  After 12 h, 8 mL of 
MeOH was added to the reaction, and the mixture was purified via dialysis (MWCO = 6 – 8 kD) 
against MeOH for 12 h.  After 12 h the mixture was concentrated in vacuo (no heating), yielding 
a solid film.  The Boc groups were removed by suspending the solid in a mixture of TFA (3.0 mL), 
DCM (1.5 mL), anisole (1.5 mL), and TIPS (0.2 mL) and stirring for 4 h under nitrogen.  The 
mixture was concentrated in vacuo (no heating), resuspended in methanol, and then precipitated 
in cold diethyl ether.  The precipitate was pelleted via centrifugation, and the supernatant was 
discarded.  The precipitate was purified via dialysis (MWCO = 6 – 8 kD) against MeOH for 24 h 
and then concentrated in vacuo.  
G3 25 TEG Backbone: Clear colorless solid. 91% isolated yield.   
G3 50 TEG Backbone: Clear colorless solid. 90% isolated yield.   
G3 75 TEG Backbone: Clear colorless solid. 93% isolated yield 
Histidine Tryptophan functionalized TEG G3 Denpols: 
See procedure for typical DP functionalization. 
G3 25 TEG 3:1 (73 H 27 W): Boc-His(Boc)-OH (9.24 equiv.) and Boc-Trp(Boc)-OH (3.08 
equiv.). Clear colorless solid. 80% isolated yield.  
G3 25 TEG 2:1 (64 H 36 W): Boc-His(Boc)-OH (8.01 equiv.) and Boc-Trp(Boc)-OH (4.31 
equiv.). Clear colorless solid. 81% isolated yield.  
G3 50 TEG 3:1 (74 H 26 W): Boc-His(Boc)-OH (6.96 equiv.) and Boc-Trp(Boc)-OH (2.32 
equiv.). Clear colorless solid. 78% isolated yield.  
G3 50 TEG 2:1 (64 H 36 W): Boc-His(Boc)-OH (6.03 equiv.) and Boc-Trp(Boc)-OH (3.24 
equiv.). Clear colorless solid. 84% isolated yield.  
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G3 75 TEG 3:1 (73 H 27 W): Boc-His(Boc)-OH (4.56 equiv.) and Boc-Trp(Boc)-OH (1.52 
equiv.). Clear colorless solid. 70% isolated yield.  
G3 75 TEG 2:1 (62 H 38 W): Boc-His(Boc)-OH (3.95 equiv.) and Boc-Trp(Boc)-OH (2.13 
equiv.). Clear colorless solid. 73% isolated yield.  
G1 PEG 2k Backbones: 
See typical procedure for functionalization of denpol G0 backbone with TEG or PEG 
G1 1.0 PEG2k Backbone: NHS-PEG2k-OMe (0.01 equiv.). Clear colorless solid. 68% isolated 
yield.   
G1 1.5 PEG2k Backbone: NHS-PEG2k-OMe (0.02 equiv.). Clear colorless solid. 59% isolated 
yield.  
G1 3.0 PEG2k Backbone: NHS-PEG2k-OMe (0.05 equiv.). Clear colorless solid. 69%% isolated 
yield.  
G2 PEG 2k Backbones: 
See typical procedure for synthesis of G2 lysine dendrons on the TEGylated (or PEG) DP 
backbones: 
G2 1.0 PEG2k Backbone: Clear colorless solid. 89% isolated yield.   
G2 1.5 PEG2k Backbone: Clear colorless solid. 71% isolated yield.    
G2 3.0 PEG2k Backbone: Clear colorless solid. 72% isolated yield.  
Histidine Tryptophan functionalized Peg 2k G2 Denpols: 
See procedure for typical DP functionalization. 
G1 1.0 PEG2k 2:1 (64 H 36 W): Boc-His(Boc)-OH (5.20 equiv.) and Boc-Trp(Boc)-OH (2.80 
equiv.). Clear colorless solid. 67% isolated yield.  
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G1 1.5 PEG2k 2:1 (67 H 33 W): Boc-His(Boc)-OH (5.20 equiv.) and Boc-Trp(Boc)-OH (2.80 
equiv.). Clear colorless solid. 74% isolated yield.  
G1 3.0 PEG2k 2:1 (65 H 35 W): Boc-His(Boc)-OH (5.20 equiv.) and Boc-Trp(Boc)-OH (2.80 
equiv.). Clear colorless solid. 68% isolated yield. 
 
 
 
Denpol mRNA transfection protocol: 
 Before performing the mRNA transfections, the area was sterilized with bleach and 
RNAase ZAP (Ambion), and special care was take to use RNAase free products when handling 
the mRNA.  Transfections were performed in triplicate in a cell culture treated clear-bottom 96-
well plate (Corning). Lipofectamine messangerMAX was used as a positive control, and was 
prepared as instructed in the manual. After synthesis, characterization, and purification of DP, a 
10 mg/mL solution was prepared using RNAase free water. DP and mRNA are mixed using the 
indicated N:P (Protonated primary amines on Denpol:Deprotonated phosphate groups on RNA) 
ratio. The mRNA was thawed and diluted to a concentration of 0.05 μg/μL with optimem buffer.  
DP was added to a 200 μL vial.  Next, the mRNA solution was added and mixed by pipetting up 
and down 10 times. Finally, the mixture is diluted with optimem such that 20 μL will contain 200 
ng of mRNA.   The mixture was then incubated at room temperature for 5 minutes.  During this 
time the culture media of the cells to be transfected was changed to 80 μL of 10% FBS in Optimem. 
20 μL of the mixture was then added to each well, and then the plate was returned to the incubator. 
Imaging of FLuc mRNA transfected cells: 
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 After the specified time of incubation with the transfection mixture, enough D-Luciferin 
was added to reach a concentration of 150 μg/mL.  After addition, the cells were incubated for 5 
minutes and then imaged using a IVIS camera to determine luminescence.  After imagining the 
cells were discarded or the culture media was changed back to 10% FBS in DMEM if further 
experimentation was required. 
 
 
Preparation of samples for dynamic light scattering (DLS) measurements: 
The FLuc mRNA was thawed and diluted to a concentration of 0.05 μg/μL with low salt 
PBS buffer.  DP was added to a 200 μL vial.  Next, the mRNA solution was added and mixed by 
pipetting up and down 10 times. The mixture was diluted to 100 μL with low salt PBS The mixture 
was incubated at room temperature for 5 minutes.  During the incubation, 80 μL of the selected 
media is added to a 100 μL cuvette.  After 5 minutes 20 μL of the mRNA DP mixture is added to 
the cuvette and mixed via pipetting up and down 10 times.  The cuvette is then placed in the 
instrument and the measurements are made. 
Procedure for confocal microscopy: 
 Confocal laser microscopy was used to track cyanine-5 labeled mRNA in the transfected 
cells. Unmodified NIH 3T3 fibroblast cells were seeded at a density of 15000 cells/well on an 8-
well chamber slide (Lab-Tek , Rochester, NY) 24h before transfection. Cy-5 labeled mRNA was 
complexed with different denpols at an N:P of 10 and transfected to the cells under the 
aforementioned conditions. Confocal fluorescence spectroscopy was performed at 4 h and 24 h 
post transfection. The nucleus was counter-stained with 0.5 μg/mL solution of Hoechst 33342. All 
confocal images were acquired using a Zeiss LSM 700 inverted laser-scanning confocal 
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microscope. A 63× plan apochromatic numerical aperture of 1.4 oil immersion DIC III objective 
or 20× plan apochromatic numerical aperture of 0.8 DIC II objective was used for all experiments. 
A 639 nm laser and a 606-700 nm band-pass filter were used to obtain the images of Cy-5 labeled 
mRNA. A 405 nm laser and a 400-498 nm band-pass filter were used to obtain the images of the 
Hoechst 33342 counter-stained nuclei. The fluorescent images were scanned separately and 
overlaid together with the differential interference contrast image (DIC). The cells were scanned 
as a z-stack of two-dimensional images (1024×1024 pixels) and an image cutting approximately 
through the middle of the cellular height was selected to present the intracellular mRNA 
localization. 
Gel shift assay to survey mRNA binding: 
The binding of mRNA to denpol was studied by agarose gel electrophoresis. Both mRNA 
and denpol were diluted with 10 mM pH 7.4 phosphate buffer. Different amount of denpol 
solutions (10 mg/mL) were added to 5 μL of a .04 μg/μL mRNA solution to achieve the specified 
N:P ratios. The same buffer was added to adjust the final volume to 10.0 µL, followed by 5 min 
incubation at room temperature. 2.5 µL 6X gel loading dye was added to each sample and 10 µL 
of the mixture was loaded to each well in 1% agarose gel with 1X GelRed dye. The electrophoresis 
was run in TAE buffer (pH 7.9) at 60 V for 45 min and the gel was visualized under a UV trans 
illuminator. 
Flow cytometry measurements: 
 Before flow cytometry, the cells are harvested from the 96 well plate via trypsin for the 
3T3 and DC 2.4 cells and pipetting for the BMDC cells followed by centrifugation. The cells are 
washed with PBS and spun down 3 additional times to remove excess Cy-5 labeled mRNA (if it 
was used).  5000 events were recorded per sample. Each value reported is the average of 3 samples. 
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LDH cytotoxicity assay: 
NIH 3t3 cells seeded in a 96 well plate were treated with denpol mRNA nanoparticles at  
an N:P ratio of 30, formulated as specified above.  After 24 h incubation with the nano particles, 
50 μL of the supernatant was taken and cytotoxicity was measured using a Pierce™ LDH 
Cytotoxicity Assay Kit (ThermoFisher) as directed in the manual. 
AFM imaging: 
Polyplexes were prepared at an N/P ratio of 10 as described above. mRNA polyplexes were 
prepared in water. After incubation for 20 min at room temperature, a drop of the solution was 
placed on freshly cleaved mica, and dried using an air gun to avoid drying effects before 
measurement. The images were all taken on an MFP-3D StandAlone AFM (Asylum Research, 
Santa Barbara, CA) through tapping-mode using a monolithic silicon TESP-10 tip (NanoAndMore 
USA, Watsonville, CA) with resonant frequency =320 kHz and a spring constant k =42 N/m. 
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1H NMR characterizations of denpols: 
1HNMR of the polymer samples used a 10 second relaxation time to ensure chain relaxation and 
to help with resolution. Methanol and water were unable to be completely removed from the 
polymer samples. The actual percentage functionalization of the Denpols as determined by 
integration is listed after the name of the denpols. As the polymer samples become more 
functionalized, the spectra become complex and peak resolution becomes difficult. Unless fully 
resolved, ranges of peaks are listed. 
G2 3:1 (77.4 H 22.6 W): 1H NMR (600 MHz, D2O) δ 8.61 – 7.97 (m, 5H), 7.70 – 6.95 (m, 13H), 
4.67 – 4.52 (m, 1H), 4.52 – 3.87 (m, 15H), 3.53 – 2.62 (m, 34H), 2.07 – 0.71 (m, 48H). 
G2 2:1 (66 H 34 W): 1H NMR (600 MHz, D2O) δ 8.58 – 8.01 (m, 5H), 7.70 – 6.88 (m, 18H), 4.67 
– 4.49 (m, 1H), 4.49 – 3.86 (m, 15H), 3.64 – 2.69 (m, 34H), 2.09 – 0.67 (m, 47H). 
G2 1:1 (55 H 45 W): 1H NMR (600 MHz, D2O) δ 8.66 – 8.02 (m, 4H), 7.69 – 6.82 (m, 19H), 4.66 
– 4.52 (m, 1H), 4.49 – 3.87 (m, 15H), 3.47 – 2.54 (m, 33H), 2.02 – 0.63 (m, 52H). 
G2 1:2 (39 H 61 W): 1H NMR (600 MHz, D2O) δ 8.62 – 7.95 (m, 4H), 7.67 – 6.80 (m, 25H), 4.64 
– 4.49 (m, 1H), 4.50 – 3.82 (m, 15H), 3.59 – 2.60 (m, 33H), 2.09 – 0.60 (m, 50H). 
G2 1:3 (27 H 73 W): 1H NMR (600 MHz, D2O) δ 8.61 – 7.95 (m, 2H), 7.70 – 6.75 (m, 28H), 4.67 
– 4.49 (m, 1H), 4.51 – 3.79 (m, 15H), 3.71 – 2.50 (m, 33H), 2.05 – 0.54 (m, 47H). 
G3 Backbone: 1H NMR (600 MHz, CD3OD) δ 4.74 – 4.56 (m, 5H), 4.57 – 4.28 (m, 8H), 4.27 – 
4.08 (m, 2H), 4.13 – 3.96 (m, 4H), 3.96 – 3.81 (m, 4H), 3.45 – 3.09 (m, 34H), 3.09 – 2.85 (m, 
19H), 2.16 – 1.07 (m, 101H). 
G3 3:1 (71 H 29 W): 1H NMR (600 MHz, D2O) δ 8.44 – 7.77 (m, 14H), 7.66 – 6.81 (m, 43H), 
4.66 – 4.52 (m, 2H), 4.43 – 3.89 (m, 35H), 3.52 – 2.61 (m, 73H), 2.08 – 0.55 (m, 105H). 
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G3 2:1 (66 H 34 W): 1H NMR (600 MHz, D2O) δ 8.21 – 7.69 (m, 12H), 7.69 – 6.71 (m, 45H), 
4.52 – 3.80 (m, 35H), 3.52 – 2.61 (m, 64H), 2.10 – 0.38 (m, 93H). 
G3 1:1 (53 H 47 W): 1H NMR (600 MHz, D2O) δ 8.17 – 7.67 (m, 11H), 7.63 – 6.68 (m, 57H), 
4.48 – 3.79 (m, 35H), 3.49 – 2.51 (m, 69H), 2.00 – 0.43 (m, 100H). 
G3 1:2 (33 H 67 W): 1H NMR (600 MHz, D2O) δ 8.22 – 7.69 (m, 11H), 7.67 – 6.70 (m, 61H), 
4.44 – 3.79 (m, 35H), 3.47 – 2.47 (m, 68H), 1.96 – 0.42 (m, 102H). 
G3 1:3 (28 H 72 W): 1H NMR (600 MHz, D2O) δ 8.04 – 7.66 (m, 6H), 7.63 – 6.70 (m, 70H), 4.49 
– 3.73 (m, 35H), 3.47 – 2.39 (m, 67H), 1.95 – 0.45 (m, 93H). 
G1 25 TEG: 1H NMR (600 MHz, CD3OD) δ 4.80 – 4.71 (m, 2H), 4.71 – 4.59 (m, 1H), 4.60 – 
4.47 (m, 0.5 H), 4.47 – 4.30 (m, 1.39H), 4.29 – 4.10 (m, 3H), 4.12 – 3.90 (m, 1.5H), 3.80 – 3.50 
(m, 6.47H), 3.36 (s, 0.7H), 3.28 – 3.11 (m, 7H), 3.10 – 2.87 (m, 4.8H), 2.04 – 1.81 (m, 4H), 1.79 
– 1.63 (m, 4H), 1.64 – 1.32 (m, 7.2H), 1.26 (t, J = 6.9 Hz, 3H). 
G1 50 TEG: 1H NMR (600 MHz, CD3OD) δ 4.72 – 4.61 (m, 1H), 4.60 – 4.49 (m, 0.47H), 4.48 – 
4.32 (m, 1.72H), 4.30 – 4.10 (m, 4H), 4.11 – 3.96 (m, 1H), 3.79 – 3.51 (m, 12.1H), 3.37 (s, 1.2H), 
3.29 – 3.08 (m, 3.67H), 3.08 – 2.86 (m, 3.9H), 2.03 – 1.81 (m, 3.16H), 1.81 – 1.65 (m, 3.02H), 
1.66 – 1.34 (m, 6.28H), 1.27 (t, J = 6.7 Hz, 3H). 
G1 75 TEG: 1H NMR (600 MHz, CD3OD) δ 4.64 – 4.50 (m, 0.65H), 4.50 – 4.32 (m, 1.54H), 4.32 
– 4.10 (m, 4.12H), 4.10 – 3.96 (m, 0.54H), 3.87 – 3.49 (m, 16.84H), 3.28 – 3.10 (m, 3.46H), 3.10 
– 2.83 (m, 2.25H), 2.04 – 1.82 (m, 1.78H), 1.84 – 1.66 (m, 1.77H), 1.66 – 1.34 (m, 4.66H), 1.34 – 
1.10 (m, 3H). 
G2 TEG 25: 1H NMR (500 MHz, CD3OD) δ 4.69 – 4.26 (m, 4H), 4.25 – 4.08 (m, 3H), 4.08 – 
3.90 (m, 1H), 3.90 – 3.76 (m, 1H), 3.76 – 3.49 (m, 6H), 3.44 – 3.03 (m, 32H), 3.04 – 2.77 (m, 7H), 
2.06 – 1.76 (m, 8H), 1.76 – 1.60 (m, 8H), 1.60 – 1.28 (m, 15H), 1.28 – 1.15 (m, 3H). 
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G2 TEG 50: 1H NMR (500 MHz, CD3OD) δ 4.63 – 4.46 (m, 1H), 4.46 – 4.27 (m, 2H), 4.27 – 
4.07 (m, 3H), 4.07 – 3.90 (m, 1H), 3.90 – 3.78 (m, 1H), 3.75 – 3.47 (m, 11H), 3.45 – 3.04 (m, 
24H), 3.03 – 2.75 (m, 5H), 2.07 – 1.76 (m, 5H), 1.76 – 1.61 (m, 5H), 1.61 – 1.29 (m, 11H), 1.29 – 
1.15 (m, 3H). 
G2 TEG 75: 1H NMR (500 MHz, CDCl3) δ 4.62 – 4.49 (m, 1H), 4.49 – 4.30 (m, 2H), 4.30 – 4.09 
(m, 4H), 4.09 – 3.94 (m, 1H), 3.94 – 3.80 (m, 1H), 3.83 – 3.48 (m, 17H), 3.48 – 3.09 (m, 11H), 
3.09 – 2.83 (m, 3H), 2.06 – 1.81 (m, 3H), 1.80 – 1.65 (m, 3H), 1.65 – 1.33 (m, 7H), 1.33 – 1.18 
(m, 3H). 
G2 25 TEG 3:1 (74 H 26 W): 1H NMR (600 MHz, CD3OD) δ 8.91 – 8.57 (m, 5H), 7.74 – 6.93 
(m, 12H), 4.59 – 3.95 (m, 14H), 3.78 – 2.72 (m, 80H), 1.93 – 1.00 (m, 69H). 
G2 25 TEG 2:1 (63 H 32 W): 1H NMR (600 MHz, CD3OD) δ 8.94 – 8.58 (m, 4H), 7.73 – 6.92 
(m, 18H), 4.59 – 3.95 (m, 21H), 3.80 – 2.74 (m, 120H), 2.16 – 1.02 (m, 98H). 
G2 50 TEG 3:1 (73 H 27 W): 1H NMR (600 MHz, CD3OD) δ 8.89 – 8.62 (m, 3H), 7.72 – 6.94 
(m, 9H), 4.52 – 3.96 (m, 18H), 3.80 – 2.79 (m, 278H), 2.09 – 1.10 (m, 38H). 
G2 50 TEG 2:1 (64 H 36 W): 1H NMR (600 MHz, CD3OD) δ 8.91 – 8.60 (m, 3H), 7.72 – 6.94 
(m, 12H), 4.60 – 3.92 (m, 16H), 3.85 – 2.73 (m, 71H), 2.15 – 1.04 (m, 47H). 
G2 75 TEG 3:1 (71 H 29 W): 1H NMR (600 MHz, CD3OD) δ 8.93 – 8.69 (m, 2H), 7.75 – 7.00 
(m, 7H), 4.63 – 4.02 (m, 18H), 3.86 – 2.78 (m, 91H), 2.11 – 1.07 (m, 41H). 
G2 75 TEG 2:1 (61 H 39 W): 1H NMR (600 MHz, CD3OD) δ 9.01 – 8.71 (m, 2H), 7.76 – 6.97 
(m, 8H), 4.69 – 3.96 (m, 16H), 3.83 – 2.77 (m, 75H), 2.10 – 1.01 (m, 35H). 
G3 25 TEG Backbone: 1H NMR (600 MHz, CD3OD) δ 4.78 – 4.69 (m, 1H), 4.69 – 4.59 (m, 1H), 
4.48 – 4.27 (m, 3H), 4.27 – 4.11 (m, 2H), 4.10 – 3.96 (m, 2H), 3.96 – 3.82 (m, 2H), 3.76 – 3.52 
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(m, 4H), 3.44 – 3.08 (m, 12H), 3.08 – 2.80 (m, 9H), 2.06 – 1.63 (m, 23H), 1.63 – 1.32 (m, 23H), 
1.32 – 1.15 (m, 3H). 
G3 25 TEG Backbone: 1H NMR (600 MHz, CD3OD) δ 4.79 – 4.70 (m, 1H), 4.69 – 4.49 (m, 1H), 
4.52 – 4.28 (m, 3H), 4.28 – 4.11 (m, 3H), 4.11 – 3.97 (m, 1H), 3.97 – 3.81 (m, 2H), 3.81 – 3.53 
(m, 9H), 3.48 – 3.09 (m, 13H), 3.09 – 2.87 (m, 7H), 2.07 – 1.65 (m, 19H), 1.65 – 1.33 (m, 19H), 
1.33 – 1.22 (m, 3H). 
G3 75 TEG Backbone: 1H NMR (600 MHz, CD3OD) δ 4.72 – 4.51 (m, 1H), 4.51 – 4.30 (m, 2H), 
4.30 – 4.12 (m, 3H), 4.12 – 3.97 (m, 1H), 3.97 – 3.84 (m, 1H), 3.83 – 3.52 (m, 13H), 3.47 – 3.11 
(m, 12H), 3.09 – 2.85 (m, 4H), 2.05 – 1.82 (m, 5H), 1.81 – 1.67 (m, 5H), 1.68 – 1.34 (m, 11H), 
1.35 – 1.21 (m, 3H). 
G3 75 TEG 3:1 (73 H 27 W): 1H NMR (500 MHz, CD3OD) δ 8.93 – 8.63 (m, 9H), 7.72 – 7.53 
(m, 3H), 7.56 – 7.31 (m, 12H), 7.31 – 7.18 (m, 4H), 7.18 – 6.95 (m, 6H), 4.82 – 4.61 (m, 1H), 4.61 
– 3.99 (m, 26H), 3.82 – 2.69 (m, 85H), 2.18 – 1.09 (m, 108H). 
G3 25 TEG 2:1 (64 H 36 W): 1H NMR (500 MHz, CD3OD) δ 8.89 – 8.51 (m, 8H), 7.67 – 7.48 
(m, 4H), 7.48 – 7.24 (m, 12H), 7.24 – 7.11 (m, 5H), 7.14 – 6.87 (m, 9H), 4.65 – 4.51 (m, 1H), 4.53 
– 3.89 (m, 26H), 3.75 – 2.76 (m, 87H), 2.05 – 1.02 (m, 103H). 
G3 25 TEG 3:1 (74 H 26 W): 1H NMR (600 MHz, CD3OD) δ 8.90 – 8.65 (m, 7H), 7.66 – 7.51 
(m, 3H), 7.51 – 7.29 (m, 9H), 7.29 – 7.16 (m, 3H), 7.16 – 6.95 (m, 4H), 4.66 – 4.55 (m, 1H), 4.52 
– 3.96 (m, 24H), 3.75 – 2.80 (m, 81H), 1.94 – 1.07 (m, 88H). 
G3 50 TEG 2:1 (64 H 36 W): 1H NMR (600 MHz, CD3OD) δ 8.91 – 8.57 (m, 6H), 7.67 – 7.51 
(m, 3H), 7.50 – 7.26 (m, 9H), 7.26 – 7.14 (m, 3H), 7.14 – 6.93 (m, 7H), 4.50 – 3.93 (m, 25H), 3.74 
– 2.77 (m, 74H), 2.00 – 1.00 (m, 72H). 
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G3 50 TEG 3:1 (73 H 27 W): 1H NMR (600 MHz, CD3OD) δ 8.91 – 8.66 (m, 4H), 7.72 – 7.54 
(m, 2H), 7.54 – 7.29 (m, 6H), 7.28 – 7.17 (m, 2H), 7.17 – 6.95 (m, 3H), 4.68 – 4.54 (m, 1H), 4.54 
– 3.97 (m, 22H), 3.77 – 2.76 (m, 76H), 2.01 – 1.00 (m, 63H). 
G3 75 TEG 2:1 (62 H 38 W): 1H NMR (600 MHz, CD3OD) δ 8.90 – 8.63 (m, 4H), 7.71 – 7.52 
(m, 2H), 7.54 – 7.29 (m, 6H), 7.28 – 7.17 (m, 2H), 7.17 – 6.95 (m, 5H), 4.66 – 4.52 (m, 1H), 4.50 
– 3.97 (m, 21H), 3.81 – 2.81 (m, 76H), 2.01 – 1.04 (m, 56H). 
G1 1.0 PEG2k Backbone: 1H NMR (600 MHz, D2O) δ 4.72 – 4.62 (m, 2H), 4.43 – 4.31 (m, 1H), 
4.30 – 4.16 (m, 2H), 4.16 – 4.01 (m, 2H), 3.80 – 3.68 (m, 1H), 3.49 – 2.91 (m, 19H), 2.05 – 1.85 
(m, 4H), 1.85 – 1.66 (m, 4H), 1.67 – 1.34 (m, 7H), 1.34 – 1.17 (m, 3H). 
G1 1.5 PEG2k Backbone: 1H NMR (600 MHz, D2O) δ 4.71 – 4.58 (m, 1H), 4.44 – 4.32 (m, 1H), 
4.30 – 4.16 (m, 1H), 4.15 – 4.01 (m, 1H), 3.81 – 3.66 (m, 1H), 3.47 – 2.93 (m, 9H), 2.08 – 1.67 
(m, 5H), 1.67 – 1.35 (m, 4H), 1.35 – 1.21 (m, 1H). 
G1 3.0 PEG2k Backbone: 1H NMR (600 MHz, D2O) δ 4.71 – 4.61 (m, 2H), 4.45 – 4.32 (m, 1H), 
4.32 – 4.18 (m, 2H), 4.18 – 4.00 (m, 1H), 3.83 – 3.65 (m, 6H), 3.34 – 2.93 (m, 9H), 2.05 – 1.85 
(m, 4H), 1.85 – 1.67 (m, 4H), 1.66 – 1.35 (m, 7H), 1.35 – 1.20 (m, 3H). 
G2 1.0 PEG2k Backbone: 1H NMR (600 MHz, CD3OD) δ 4.77 – 3.95 (m, 8H), 3.97 – 3.83 (m, 
2H), 3.76 – 3.62 (m, 2H), 3.44 – 3.10 (m, 14H), 3.10 – 2.85 (m, 9H), 2.12 – 1.82 (m, 11H), 1.81 – 
1.67 (m, 10H), 1.67 – 1.33 (m, 20H), 1.33 – 1.19 (m, 3H). 
G2 1.5 PEG2k Backbone: 1H NMR (600 MHz, CD3OD) δ 4.75 – 4.26 (m, 5H), 4.26 – 3.96 (m, 
3H), 3.96 – 3.79 (m, 1H), 3.76 – 3.59 (m, 2H), 3.47 – 3.08 (m, 20H), 3.08 – 2.86 (m, 8H), 2.13 – 
1.81 (m, 9H), 1.81 – 1.66 (m, 9H), 1.66 – 1.33 (m, 17H), 1.33 – 1.16 (m, 3H). 
G2 3.0 PEG2k Backbone: 1H NMR (600 MHz, CD3OD) δ 4.76 – 4.29 (m, 4H), 4.27 – 4.13 (m, 
2H), 4.15 – 3.95 (m, 2H), 3.95 – 3.83 (m, 2H), 3.78 – 3.61 (m, 7H), 3.50 – 3.09 (m, 24H), 3.09 – 
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2.89 (m, 8H), 2.14 – 1.82 (m, 10H), 1.82 – 1.67 (m, 10H), 1.67 – 1.34 (m, 18H), 1.34 – 1.21 (m, 
3H). 
G1 1.0 PEG2k 2:1 (64 H 36 W): 1H NMR (600 MHz, CD3OD) δ 8.14 – 7.81 (m, 5H), 7.68 – 7.50 
(m, 3H), 7.43 – 7.29 (m, J = 6.4 Hz, 3H), 7.29 – 6.82 (m, 14H), 4.76 – 4.61 (m, 2H), 4.58 – 3.94 
(m, 19H), 3.71 – 2.77 (m, 71H), 2.05 – 1.05 (m, 60H). 
G1 1.5 PEG2k 2:1 (67 H 33 W): 1H NMR (600 MHz, CD3OD) δ 8.28 – 7.87 (m, 5H), 7.71 – 7.52 
(m, 2H), 7.44 – 7.29 (m, 3H), 7.29 – 6.89 (m, 13H), 4.72 – 4.59 (m, 2H), 4.57 – 3.95 (m, 18H), 
3.75 – 2.78 (m, 69H), 2.01 – 1.03 (m, 61H). 
G1 3.0 PEG2k 2:1 (65 H 35 W1H NMR (600 MHz, CD3OD) δ 8.19 – 7.82 (m, 5H), 7.75 – 7.55 
(m, 3H), 7.44 – 7.31 (m, 3H), 7.32 – 6.93 (m, 13H), 4.77 – 4.63 (m, 1H), 4.57 – 4.00 (m, 18H), 
3.75 – 2.83 (m, 58H), 2.13 – 1.05 (m, 73H). 
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1H NMR sepctra of denpols: 
G2 3:1 (77 H 23 W): 
 
G2 2:1 (66 H 34 W):
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G2 1:1 (55 H 45 W): 
 
G2 1:2 (39 H 61 W): 
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G2 1:3 (27 H 73 W): 
 
G3 Backbone: 
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G3 3:1 (71 H 29 W): 
 
G3 2:1 (66 H 34 W): 
 
126 
 
 
G3 1:1 (53 H 47 W): 
 
G3 1:2 (33 H 67 W): 
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G3 1:3 (28 H 72 W): 
 
G1 25 TEG: 
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G1 50 TEG: 
 
G1 75 TEG: 
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G2 TEG 25: 
 
G2 TEG 50: 
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G2 TEG 75: 
 
G2 25 TEG 3:1 (74 H 26 W): 
 
131 
 
 
G2 25 TEG 2:1 (63 H 32 W): 
 
G2 50 TEG 3:1 (73 H 27 W): 
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G2 50 TEG 2:1 (64 H 36 W): 
 
G2 75 TEG 3:1 (71 H 29 W): 
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G2 75 TEG 2:1 (61 H 39 W): 
 
G3 25 TEG Backbone: 
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G3 50 TEG Backbone: 
 
G3 75 TEG Backbone: 
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G3 25 TEG 3:1 (73 H 27 W): 
 
G3 25 TEG 2:1 (64 H 36 W): 
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G3 50 TEG 3:1 (74 H 26 W): 
 
G3 50 TEG 2:1 (64 H 36 W): 
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G3 75 TEG 3:1 (73 H 27 W): 
 
G3 75 TEG 2:1 (62 H 38 W): 
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G1 1.0 PEG2k Backbone: 
 
G1 1.5 PEG2k Backbone: 
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G1 3.0 PEG2k Backbone: 
 
G2 1.0 PEG2k Backbone: 
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G2 1.5 PEG2k Backbone: 
 
G2 3.0 PEG2k Backbone: 
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G1 1.0 PEG2k 2:1 (64 H 36 W): 
 
G1 1.5 PEG2k 2:1 (67 H 33 W): 
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G1 3.0 PEG2k 2:1 (65 H 35 W): 
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Flow Cytometry Output: 
DC 2.4 cells 
LF MM 
 
mRNA only 
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G2 3:1 
 
G2 2:1 
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G2 25 TEG 2:1 
 
G2 25 TEG 3:1 
 
  
146 
 
G2 50 TEG 3:1 
 
G2 50 TEG 2:1 
 
  
147 
 
G2 75 TEG 3:1 
 
G2 75 TEG 2:1 
 
  
148 
 
G2 1.0 PEG 2k 2:1 
 
G2 1.5 PEG 2k 2:1 
 
  
149 
 
G2 3.0 PEG 2k 2:1 
 
BMDC Cells 
LF MM 
 
  
150 
 
mRNA only 
 
G2 3:1 
 
  
151 
 
G2 2:1 
 
G2 25 TEG 2:1 
 
  
152 
 
G2 25 TEG 3:1 
 
G2 50 TEG 3:1 
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G2 50 TEG 2:1 
 
G2 75 TEG 3:1 
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G2 75 TEG 2:1 
 
G2 1.0 PEG 2k 2:1 
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G2 1.5 PEG 2k 2:1 
 
G2 3.0 PEG 2k 2:1 
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Chapter 5 : Mechanical Gradient Formation via Metal-Ligand Interactions 
Abstract: 
Mechanical gradients are often employed in nature to prevent damage from large forces by 
creating a smooth transition from strong to weak biological materials. Synthetic mimics of these 
natural structures are highly desired to improve distribution of stresses at interfaces, and reduce 
contact deformation in non-biological materials. Current synthetic gradient materials suffer from 
steep, irregular transitions and relatively small ranges in mechanical properties. Inspired by the 
polychaete worm jaw, we report a novel route to generate stiffness gradients in polymeric materials 
via incorporation of monodentate, dynamic metal-ligand crosslinks. Through spatial control of 
metal ion content, we create a continuous mechanical gradient that spans over a 100-fold difference 
in stiffness. 
5.1: Introduction 
Materials that provide form and function in living organisms generate and withstand 
tremendous forces. For example, the club of a peacock mantis shrimp (Odontodactylus scyllarus) 
can experience up to 700 N during a strike.1 This massive force must be ameliorated when 
transferring between the hard club and soft tissues of the shrimp to prevent serious damage. 
Cleverly, the dissipation of these forces is accomplished through a continuous gradient in 
mechanical properties from hard to soft. Gradients like this allow the forces to be distributed over 
a large area to prevent stress buildup and catastrophic failures in the tissues of living organisms.2 
Synthetic analogs of these natural mechanical gradients have been long pursued to create stronger 
materials with improved thermal stress dissipation, mechanical stress dissipation, and fracture 
toughness at interfaces.2  
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Synthetic mechanical 
gradients are generally 
obtained in a layered or lateral 
orientation. Layered gradients 
are printed layer-by-layer onto 
surfaces and are not true 
continuous gradients due to the 
segmented fabrication 
process.3-5 Some lateral 
gradients are able to obtain 
smooth transitions,6-10 but there 
are fewer examples due to the higher synthetic effort required to generate them. Notable examples 
of previously reported lateral gradients include photoinduced crosslinking of cellulose nano 
crystals,7 ordering of carbon nanotube films,11 and cellulose nanofibril/polymer nanopapers.12 
While these and other synthetic analogs are functional mechanical gradients,6, 8-10, 13-18 they often 
suffer from relatively small ranges in stiffness (~ 1 order of magnitude), noncontiguous stepwise 
transitions, and require specialty equipment to fabricate. To improve upon these systems, we 
sought a synthetic solution that could span a greater range of mechanical properties with a true 
continuous gradient and facile synthesis.  
Many examples of gradient materials exist in nature19-24, but when searching for routes to 
gradient formation, the jaw of the polychaete worm became a unique source of inspiration (Figure 
5.1). In contrast to the mineralization and covalent crosslinking used to form many natural 
gradients25-27, the polychaete worm relies on metal-ligand interactions to create a rigid jaw tip to 
Figure 5.1 Comparison of the gradient found in the Polychaete worm jaw and the 
gradient made in this work 
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inject venom.25-27 Specifically, by creating a gradient of zinc (or copper) through a histidine rich 
protein network, the increasing number of metal-histidine interactions act as crosslinks and create 
a mechanical gradient, which can prevent damage to the jaw tip during biting and venom injection.  
Our previously reported studies investigated control of mechanical properties by altering 
metal identity (Zn, Cu, Co) and concentration in an imidazole metallopolymer network. 28, 29 We 
employed monodentate imidazole ligands to create dynamic metal-ligand crosslinks, which in the 
presence of a weakly binding solvent (acetonitrile, ACN) facilitated ligand exchange and metal 
incorporation (no gelation). Upon solvent removal the rate of ligand exchange was sufficiently 
lowered to create appreciable crosslinks that tuned mechanical properties based on metal 
concentration. 
5.2: Results and Discussion 
Herein, we leverage our understanding of monodentate, labile imidazole ligands to 
generate a gradient crosslinked metallopolymer network, to achieve gradient mechanical 
properties mimicking the polychaete jaw (Figure 5.1). To incorporate a gradient of metal into the 
material, we imagined that we could suspend a polymer sample in a metal solution, and slowly 
raise it out of the solution while increasing metal concentration. The dynamic nature of the 
crosslink in the presence of ACN would allow for rapid crosslink exchange and metal 
incorporation into the bulk of the material. Subsequently, upon removal of the solvent, the dynamic 
metal-ligand interactions would have drastically lowered exchange rates, increasing the local 
hardness and Young’s modulus (E).  The synthesis of the imidazole-containing network (ICN) is 
described in Figure 5.2A. An imidazole-containing acrylate monomer (IMZa) was copolymerized 
with butyl acrylate (BA) and 1,4-butanediol diacrylate (BDDA) via UV-initiated polymerization 
to achieve the ICN.  BA was used to lower the glass transition temperature, enhance ligand 
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mobility, and create an initial polymer 
with the desired mechanical 
properties. The BA, IMZa and BDDA 
were used in a 66.5:33:0.5 mol ratio, 
respectively, to achieve the polymer 
network. These monomer 
incorporation ratios were selected 
based on our previous study, where 
IMZa incorporation over ~35 mol% 
gave diminished returns of increased 
mechanical properties.29 After the 
synthesis of the ICN, a metal salt (Zn, 
Cu, or Co) was incorporated via 
controlled diffusion to form ICN-M. 
[Bis(trifluoromethylsulfonyl)-imide] 
(NTF) was selected as the counter ion 
for all metals due to its well-
characterized behaviour, thermal stability, and high mobility in the solid state. 
To create the metal gradient, a simple device was designed from a common laboratory 
syringe pump. The device, termed a continuous gradient patterner (CGP, Figure 5.2C) works by 
first attaching the polymer sample via string to the pusher block of the syringe pump and then 
suspending the sample in a graduated cylinder with lightly stirring solution of a metal NTF salt 
dissolved in ACN. A 1 mL syringe containing a highly concentrated metal NTF salt solution in 
Figure 5.2 A) Synthetic route used to achieve the ICN. B) Cartoon 
depicting metal incorporation into the ICN to form ICN-M. C) Cartoon 
depicting the use of a common laboratory syringe pump to fashion the CGP 
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ACN was adjusted to the length of the 
sample, such that, while the additional 
metal solution was being injected into the 
graduated cylinder, the sample would be 
slowly raised out of the solution, allowing 
a gradient to be formed. All ICN-M 
gradient samples were formed starting 
with the molar ratio of 0.167 metal atoms 
per imidazole. During the continuous 
CGP process, more metal salt was 
gradually added to finally raise the molar 
ratio to 0.25 metal atoms per imidazole in 
the end (See SI for detailed calculations). 
These selected values were determined 
experimentally, as both too much (Figure 5.5) and too little added metal resulted in consistently 
weaker materials. The syringe pump was set on the lowest flow rate, which typically allowed the 
polymer sample to raise out from the metal solution over 2 days, giving sufficient time for the 
metal to incorporate into the bulk. After completion of the process, any residual solvent was 
removed from the crosslinked samples in a vacuum oven. 
After the metal incorporation and removal of ACN, the mechanical properties of ICN-M 
samples were studied via nanoindentation using a Nanovea nanoindenter. The Young’s modulus 
(stiffness, E) and local hardness were calculated based on single indentation of a spherical tip. 
Nanoindentation was selected for characterization because it is non-destructive and allows for 
Figure 5.3 A) Spatial Young's modulus as determined by Nano 
indentation. B) Relative metal concentration along the lateral axis as 
determined by XPS C) Image of the ICN-Cu sample 
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small and precisely controlled testing areas. Each ICN-M sample was tested along its length axis 
to illustrate gradient formation. Young’s modulus results (Figure 5.3A) illustrate that the highest 
stiffness for all ICN-M samples occur at the end of the sample in the metal solution the longest 
and that all samples display gradual stiffness decrease along their length axis. ICN-Zn displayed 
the highest stiffness for all tested samples at 108 ± 7 MPa (Table 5.1). Additionally, ICN-Zn 
possessed the largest and most gradually decreasing gradient span from 108 ± 7 to 0.59 ± 0.04 
MPa. To the best of our knowledge, at over two orders of magnitude (227 fold increase), this 
stiffness gradient represents the largest, continuous synthetic mechanical gradient made to date. In 
fact, this range in stiffness closely matches the magnitude of gradient observed in squid beaks, a 
benchmark for many gradient materials.20 After ICN-Zn, ICN-Cu displayed the next highest 
maximum stiffness (46.1 ± 0.8 MPa), followed by ICN-Co (25 ± 2 MPa)(Table 5.1). The local 
hardness of all specimens was also determined via nanoindentation (Figure 5.6, Table 5.3). In 
general, the observed hardness gradients spanned over one order of magnitude. Interestingly, ICN-
Co displays the highest hardness of all samples, rather than ICN-Zn. This may be because Co-
imidazole complexes exist as ML6 species, while Zn-imidazole complexes exist as ML4 
complexes. This higher degree of crosslinks per metal atom could lead to a higher resistance to 
permanent shape change i.e. hardness.  
To confirm that the stiffness and hardness gradient was arising from the incorporation of a 
gradient of metal ions, X-ray Photoelectron Spectroscopy (XPS) using a Kratos Axis SUPRA, was 
employed to determine relative metal concentrations along the lateral axis of the specimen.  XPS 
was chosen because it can detect small metal concentrations, examine spatially distinct locations 
along the lateral axis, and is generally non-destructive to the sample. An argon gas cluster ion 
source (GCIS) was used to remove surface contaminants (Ar2000+, 5 keV) and observe the bulk 
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material. Region scans of the major atomic components (C, O, N) of the ICN were used to 
determine the relative abundance of the metal ions (Zn, Cu, and Co) and confirm that the correct 
atomic ratios of elements were present for the ICN. Indeed, along the lateral axis of the specimen, 
gradients of all 3 metals were observed (Figure 5.3B). ICN-Zn contains the largest relative 
percentage of metal (ranging from 0.9 – 5.1%, Table 5.2) while ICN-Co and ICN-Cu contained 
less relative metal (ranging from 0.35 – 1.13 % and 0.1 – 1.21 % respectively, Table 5.2).  Depth 
profiling using a 20 keV 2000 Ar+ GCIS suggests that the metal is able to penetrate into the bulk 
of the material in similar relative amounts (Figure 5.7). Determination of metal concentration 
below 1 mm was not accurate as the survey area of the XPS must be kept away from the edge to 
minimize interference from the carbon tape used to adhere the sample to the slide. The excellent 
correlation between the metal concentration gradient observed by XPS and the mechanical 
gradient observed via nanoindentation implies that metal-imidazole interactions cause the 
strengthening of the material. We hypothesize that the dramatic change in stiffness over the last 1 
mm of the material may be due to the ability of the metal to permeate better into the end of the 
material from the great surface area exposed to the solution, and is also in the solution the longest. 
This spike in stiffness may also be related to the changing metal to ligand ratio. In our previous 
study29, we observed significant changes in Young’s modulus between 0.22 and 0.25 metal atoms 
per imidazole. If the sample is in this range at the end of these samples, a similar dramatic increase 
in Young’s modulus could be observed. Incorporation of the metal into the polymer at the molar 
ratio of 0.25:1 would give roughly 7.5 mol % metal. Especially in the case of the zinc, we imagine 
that the bulk mol % of metal is closest to approaching this ideal amount. 
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Table 5.1 Minimal and maximal stiffness of each ICN material. 
 
Metal Max E[a] Min E[a] Fold Increase 
Zinc 107 ± 7 0.47 ± 0.02 227 
Copper 46 ± 1 0.34 ± 0.01 135 
Cobalt 25 ± 2 0.38 ± 0.01 66 
[a] Young’s modulus (E) is measured in MPa 
 
 
Table 5.2 Minimal and maximal relative metal amount of each ICN material. 
Metal Max Metal mol %[a] Min Metal mol %[a] Fold Increase 
Zinc 5.1 ± 0.5 0.9 ± 0.4 5.7 
Copper 1.13 ± 0.07  0.35 ± 0.05 3.2 
Cobalt 1.21 ± 0.06 0.11 ± 0.01 11.2 
[a] Metal mol % was determined via XPS and is relative to the carbon, 
nitrogen and oxygen content of the polymer 
 
While the same metal concentrations for M-NTf solutions were used for all samples during 
swelling, the gradient behaviour for ICN-M samples differed based on metal selection. ICN-Zn 
formed a significantly stiffer gradient than both ICN-Cu and ICN-Co. This agrees with the XPS 
data, which demonstrates the ICN-Zn had higher metal incorporation across the lateral axis. In an 
attempt to rationalize why ICN-Zn would have more metal than ICN-Co and ICN-Cu, we note 
here that Zn2+ species are known to form only ML4 complexes with imidazole ligands, while Co
2+ 
and Cu2+ can from six coordinate species.28, 29 While studying complexation of metal into a swollen 
polymer is not straightforward, we hypothesize that higher coordination number would hinder 
penetration of the metal deeper into the sample. This dissimilar metal mobility could affect 
network formation. We are currently pursuing routes to better quantify these possible effects.  
 
5.3: Conclusions 
In summary, the ICN-Zn network demonstrated in this work represents the largest 
continuous gradient change in mechanical properties observed to date at over 2 orders of 
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magnitude. While this alone is a dramatic improvement in these types of materials, the accessibility 
and ease of synthesis is another marked improvement. Using only a 2-step synthesis and common 
laboratory syringe pump, the ICN-M gradient materials can be reliably produced. With more 
rigorous engineering control (pull rate, temperature, metal added) we think gradients with over 3 
orders of magnitude in young’s modulus could feasibly be obtained. In addition, the flexibility of 
this system will allow for a variety of different mechanical gradients to be studied using different 
metals, labile ligands, and counterions. Ongoing studies pursuing these goals, as well as gaining 
more mechanistic insight are currently being completed in our lab. 
5.4 Supporting Information  
General Information 
1H NMR spectra were recorded at 500 MHz. Chemical shifts were reported in standard 
format as values in ppm relative to the signal of deuterated solvents. All metal salts were stored 
and weighed in a Nitrogen glove box to minimize water absorption and ensure accurate 
measurements. Cu(NTf2)2 was purchased from Aldrich. Zn(NTf2)2 was purchased from Strem 
Chemicals, Inc. Co(NTf2)2 was purchased from Alfa Aesar. Cu(NTf2)2 was obtained in hydrate 
form and the water content, reported in the Certificate of Analysis (determined by Karl Fischer 
titration), was used to calculate the molecular weight of the copper hydrate. For butyl acrylate, 
inhibitors were removed by passing through basic alumina column prior to polymerization. 1-
hydroxycyclohexyl phenyl ketone, technical grade, was used as received and was not passed 
through basic column before polymerization. UV polymerization was performed with a UVP BL-
15 longwave UV lamp (P/N 95-0130-01, 0.305 amps, 120 V, 60 Hz) at a distance of approximately 
1.5 inches. The syringe pump used in the CGP was a Fisher Scientific model No. 78-01001. 
Synthesis and polymerization 
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Synthesis of IMZa 
 
The synthesis of IMZa was carried out as previously described.28 Characterization matched 
previous literature values.  
Polymerization of ICN 
 
In a glass vial IMZa (7.44 mmol, 1.98 g, 33 mol%), butyl acrylate (13.7 mmol, 1.76 g, 66.8 mol%), 
butane diol diacrylate (0.0744 mmol, 0.0147 g, 0.2 mol%), and 1-hydroxycyclohexyl phenyl 
ketone (0.0751 g, 2 wt% w.r.t. total monomer) were combined. Next, reagents were purged with 
N2 for 5 minutes. After purging, a small amount of monomer solution was saved for NMR analysis 
to determine the exact amount of IMZa in the monomer solution. The purged monomer solution 
was transferred to a Teflon dish (54 mm x 35 mm x 1.5 mm) and pre-polymerized with UV light 
for 5 minutes. The viscous gel was then covered with a plastic overhead slip and weighted glass 
sheet, followed by UV irradiation for 30 min. After polymerization, the ICN sheet was peeled from 
the Teflon mold and plastic sheet, before being stored under vacuum to prevent imidazole 
oxidation. The mol% of IMZa in ICN was calculated from the monomer mixture, as the ratio of 
imidazole peaks to acrylate peaks. 
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Figure 5.4 Monomer mixture from ICN polymerization. IMZa peak at 7.0 ppm was compared to BA peak at 0.9 ppm to determine 
IMZa percentage. 
Formation of the Gradient Material 
The polymer sample is suspended using tweezers in 90 mL of a stirring acetonitrile solution with 
the appropriate amount of metal (vida infra). The other end of the string is attached to the pusher 
arm of a syringe pump using tape. Using a 1 mL syringe and tubing, the amount of metal to be 
added (vida infra) is dissolved in an amount of acetonitrile equivalent to the swollen length of the 
polymer. For example, if the sample is 3 cm long while swollen, the plunger of the syringe (with 
the tubing attached, to account for the dead volume of the tubing) is drawn up 3 cm and that volume 
is used. The added solution concentration can vary slightly due to the adjustment for length for 
each sample. The end of the tubing is placed in the stirring solution, and the syringe pump is 
started. The syringe pump was set to a speed that allowed the sample to be slowly pulled up over 
2 days. See Image of Apparatus below. 
172 
 
 
Calculation of swell solution concentration 
Since the mol % of IMZa is known, the mmol of imidazole per length can be determined 
using the mass and length of the polymer. Using equation S1 the total metal needed (in mmol) at 
length l to form the gradient can be calculated: 
Equation 5.1:  𝑇𝑜𝑡𝑎𝑙 𝑚𝑚𝑜𝑙 𝑚𝑒𝑡𝑎𝑙 = ∫ 𝑥 (𝑦𝑓 − (𝑦𝑓 − 𝑦𝑖)
𝑙
𝑙𝑖
) 𝑙
𝑙𝑖
𝑙𝑓
𝑑𝑙 
Where: 
x = mmol of IMZa per length 
yf = final metal atoms per IMZa 
yi = initial metal atoms per IMZa 
li = initial length submerged in solution 
lf = final length submerged in solution 
Then using equation S2 the initial amount of metal needed can be calculated:  
Equation 5.2:  𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑚𝑚𝑜𝑙 𝑚𝑒𝑡𝑎𝑙 𝑛𝑒𝑒𝑑𝑒𝑑 = 𝑥 × 𝑦𝑖 × 𝑙𝑖 
Finally Equation S3 is used to determine the amount to add via the syringe: 
Equation 5.3: 𝑚𝑚𝑜𝑙 𝑚𝑒𝑡𝑎𝑙 𝑛𝑒𝑒𝑑𝑒𝑑 𝑖𝑛 𝑠𝑦𝑟𝑖𝑛𝑔𝑒 = 𝑇𝑜𝑡𝑎𝑙 𝑚𝑚𝑜𝑙 𝑚𝑒𝑡𝑎𝑙 − 𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑚𝑚𝑜𝑙 𝑚𝑒𝑡𝑎𝑙 
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Bulk characterization 
Instrumented indentation procedure of ICN-M samples 
The hardness and modulus of elasticity were measured by nanoindenter (Nanovea, Irvine, CA, 
USA) using a spherical-conical diamond indenter with tip radius and cone angle of 100µm and 
120° respectively. The depth and compliance of the instrument was calibrated with fused silica 
prior to testing, and all tests were performed at 40% humidity and 23°C. In order to stay within the 
spherical zone of the indenter tip (0-28.5µm), the applied load was based on the hardness of the 
sample at each test location. The loading rate was based on the applied load so that loading and 
unloading would each take 30 seconds. The resting period at maximum load was always 2 minutes 
to reduce the effect of creep on the elastic modulus measurement. The applied load and loading 
rate ranged from 0.5-20mN and 1-40mN/min respectively. The hardness and elastic modulus were 
calculated using ASTM E2546 (the Oliver & Pharr method). 
Instrumented indentation of preliminary ICN-M samples 
 
Figure 5.5 Preliminary data for higher metal content (0.1 copper per imidazole initial, 1 copper per imidazole final) ICN-Cu shows 
weaker ICN-Cu stiffness. 
Tabulated Young’s modulus data 
Table 5.3 Stiffness of ICN-M samples associated with Figure 5.3A. 
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 Young’s modulus by Metal (MPa)  Young’s modulus by Metal (MPa) 
Position 
(mm) 
Zinc Copper Cobalt 
Position 
(mm) 
Zinc Copper Cobalt 
0.1 108 ± 7 46 ± 0.8 25 ± 2 4 7.1 ± 0.5 1.8 ± 0.3 5.4 ± 0.1 
0.2 59 ± 2 32 ± 3 17.8 ± 0.6 6 4.0 ± 0.4 1.21 ± 0.05 3.52 ± 0.09 
0.4 45 ± 7 20 ± 2 14 ± 1 8 3.4 ± 0.2 1.05 ± 0.02 1.5 ± 0.2 
0.6 29 ± 4 14 ± 1 12.8 ± 0.8 10 1.49 ± 0.05 0.94 ± 0.01 1.6 ± 0.1 
0.8 22 ± 1 7.0 ± 0.6 12 ± 1 15 1.1 ± 0.1 0.85 ± 0.01 1.15 ± 0.02 
1 19 ± 1 4 ± 1 9.5 ± 0.2 20 0.63 ± 0.03 0.70 ± 0.01 0.87 ± 0.02 
1.5 16.3 ± 0.6 3.0 ± 0.1 7.6 ± 0.2 25 0.59 ± 0.04 0.61 ± 0.01 0.63 ± 0.01 
2 7.3 ± 0.6 2.5 ± 0.2 7.2     
 
 
 
Hardness data of ICN-M samples 
  
Figure 5.6 Spatial Hardness as determined by Nano indentation. 
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X-ray photoelectron spectra were obtained using a Kratos AXIS Supra device. All measurements 
were made at a vacuum of < 5 e -7 torr. All samples were mounted to glass microscope slides using 
double-sided carbon tape. Region scans were obtained using a monochromic aluminum source at 
an energy of 1486.69 eV, a magnification of 1 e 37, and a resolution of 20. All surfaces were 
cleaned using GCIS 2000 Ag+ 5 keV etching over 12 minutes before region scans were collected. 
Regions scans of the Cu (3/2 2p), Zn (3/2 2p), Co (3/2 2p), O (1s), N (1s), and C (1s) were collected 
in the ranges of 965-925 eV, 1057-1012 eV, 810-773 eV, 543-525 eV, 410-390 eV, 300-277 eV 
respectively. Integrated regions from the C, O, N regions, as well as the appropriate metals were 
divided by their relative sensitivity factor to derive the mol % of each element. Region scans were 
taken at 1, 3, 8, 13, 18, and 23 mm from the hard end of the sample. Depth profiling studies were 
carried out using a more powerful GCIS (Ar 2000+ 20 eV) over 100 minutes. Etching was 
performed for 10 minutes then region scans were performed. During the depth profiling 
experiments, only region scans of the metal of interest and carbon were collected to minimize the 
time the GCIS filament was active.  
Table 5.4 Tabulated XPS data of Figure 5.3B. 
Distance 
from hard 
end (mm) 
mol % Zn[a] St. Dev. Zn mol % Cu[a] St. dev. Cu mol % Co[a] St. dev. Co 
1 5.1 0.45 1.13 0.079 1.21 0.064 
3 4.3 0.42 0.92 0.075 0.95 0.053 
8 2.1 0.40 0.62 0.073 0.74 0.046 
13 1.8 0.36 0.54 0.065 0.40 0.032 
18 1.0 0.40 0.42 0.065 0.27 0.021 
23 0.9 0.43 0.35 0.050 0.20 0.018 
[a] Relative to mol % of C, O, and N 
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XPS Depth Profiling 
 
Figure 5.7 Depth profiling with a 20 keV 2000 Ar+ GCIS. Measurements were take 5.5 mm from the stiff end. mol % was calculated 
only relative to carbon, due to the limited time the GCIS filament could be active. 
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